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ABSTRACT
Pannexins (Panxs) are a recently identified family of channel-forming glycoproteins,
comprised of three members: Panx1, Panx2 and Panx3. Panxs were classified as
gap junction (GJ) proteins based on their shared sequence homology to the
invertebrate GJ protein, innexins. While no sequence homology exist between
Panxs and the GJ proteins, connexins (Cxs), they share similar topology with four
transmembrane domains, two extracellular loops, an intracellular loop and
cytoplasmic exposed amino and carboxy terminal tails. In this study, we investigated
if Panx1 and Panx3 exhibit unique or shared properties of cell surface delivery,
mobility, cytoskeletal dependency, internalization and degradation, to the well
characterized Cx43 GJ protein. Over-expression of a dominant-negative Sar1
mutant revealed that, like Cx43, Panx1 and Panx3 followed the classical secretory
pathway en route to the cell surface. At the plasma membrane, Panx1 and Panx3
distributed in a relatively uniform pattern independent of the presence of an adjoining
cell, a feature distinct from the punctate localization of Cx43 at cell-cell apposition.
Rapid time-lapse imaging and photo-bleaching revealed high mobility of Panx1 and
Panx3 at the cell surface, unlike Cx43-GJs. Using pharmacological inhibitors of
microtubule and microfilament polymerization, Panx1 and Panx3 were identified to
rely primarily on actin filaments for their overall cell surface stability. Interestingly, cosedimentation and co-immunoprecipitation assays revealed that actin bound directly
to the C-terminal tail of Panx1. Truncation of the Panx1 C-terminal tail at residue 307
(Panx1T307) inhibited its trafficking to the cell surface causing it to be retained within
the endoplasmic reticulum. Co-expression of full length Panx1 could not rescue the
iii

delivery of Panx1T307 to the cell surface but exhibited limited co-interaction. Blocking
of protein synthesis and secretion revealed a prolonged half-life of Panx1 in
comparison to Cx43. Rapid time-lapse imaging of cells expressing Panx1-GFP
uncovered a unique pattern of Panx1 internalization through dynamic tubular-like
extensions.

Chloroquine-induced inhibition of lysosomal function revealed that

Panx1 is degraded by lysosomes. Collectively, our studies show that Panx1 and
Panx3 exhibit many properties that are distinct from Cx43, further supporting that
pannexins forms a unique class of channel proteins that should be considered
separate from connexin-based GJ channels.

Keywords
Pannexins, connexin43, rapid time-lapse imaging, fluorescence recovery after
photo-bleaching and cytoskeletal elements
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CHAPTER 1

2

1

INTRODUCTION

1.1 Evolutionary aspect of innexins, connexins and
pannexins
A family of channel forming proteins, termed pannexins (Panxs), was first
identified in the year 2000 by Panchin and colleagues [1]. Pannexins were
discovered as the vertebrate homologs of invertebrate gap junction proteins,
innexins (Inxs) [1, 2], and were therefore proposed to share functional features
similar to gap junctions.
Gap junctions (GJs) are tightly packed intercellular channels that are assembled
from two halves or hemi-channels composed of GJ proteins [3, 4]. GJ channels
connect the cytoplasm of two apposing cells for bi-directional passage of ions,
small metabolites and messenger molecules less than 1 kDa in size [4, 5]. The
intercellular communication mediated by GJ channels regulates physiological
processes

related

to

development,

synchronization,

differentiation

and

proliferation [6-8].
In the 1980s, the pioneer work done on characterizing GJs led to the
identification of a multigene family of vertebrate proteins, connexins (Cxs) [9, 10],
and the nomenclature of Cxs was based according to their predicted molecular
mass [9, 10]. Ever since the cloning of the first connexin, Cx32, from rat and
human liver [11, 12], 20 murine and 21 human connexin family members have
been identified [13]. Based on the cDNA and genomic sequences, Cxs were also
evident in animals of chordate branch: tunicates, ascidians and appendicularians
(GenBank accession numbers AY380580, AY386312, AY386311) [14]. Despite
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being a large family, several initiatives could not identify connexin homologs in
the genomes of Caenorhabditis elegans (nematode) or Drosophila melanogaster
(arthropod), thereby suggesting an existence of a distinct family of proteins for
the formation of GJs in invertebrates [15]. A second GJ protein, unrelated to
Cxs, was then found in several bilaterian protostome phylas including
Platyhelminthes, Nematoda, Annelida, Molluscs and Arthropoda (Figure 1.1).
This family of proteins was originally designated as OPUS, derived from the
founding members: ogre, Passover, unc-7 and shaking-B, but were later
renamed innexins (invertebrate analog of connexin) based on their shared ability
to form intercellular channels, like connexins [16-20].
With the renaming of invertebrate GJs to innexins, the genomic sequence of
mollusk and flatworm were aligned and compared against the human genome
using a PSI-BLAST (Position Specific Iterative-Basic Local Alignment Search
Tool) approach [21]. The BLAST search identified two mRNA sequences with no
previously assigned functions that encoded MRS1 (GenBank accession number
AF093239) and MRS1-related proteins (GenBank accession number AL022328).
Interestingly, sequence searches based on the MRS1 protein retrieved the
invertebrate gap junction protein, Unc-7 from C. elegans, thus expanding the
innexin homolog family into the chordata phyla [21].

Due to the apparent

ubiquitous presence of this family of proteins in the metazoan animal kingdom,
and their putative role as GJs, they were termed ‘pannexins’ (from the Latin Panall, throughout and nexus- connection) [1, 21]. As a result, the human MRS1
protein was denoted as PANX1, and its related form as PANX2. In addition, a
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protein sequence query (TBLASTN) applied against the human genome detected
a final member of this family, PANX3 [21].
From an evolutionary perspective, it appeared that innexins emerged to provide
gap junctional intercellular communication in animals of Cnidarian lineage, which
was later inherited by protostomes and deuterostomes (Figure 1.1). In
comparison, Cxs emerged in deuterostomes as a second class of GJ proteins,
presumably by a gene duplication in the early protochordate lineage [22]. This
divergence led innexins to be found in a subfamily within deuterostomes- as
pannexins [23].
Connexins were originally identified to be chordate-specific, however, additional
genomic sequence analysis from other organisms have shown some exception
to this criteria, as animals (e.g. lancelets) within one of the branches of the
chordata phylum (cephalochordate) are devoid of connexins, but have pannexins
[24] (Figure 1.1).
From the functional point of view, pannexins might have emerged to provide
compensatory, overlapping or unique physiological roles compared to that of
connexins. The assessment of the phylogenetic relationship between different
members of this superfamily has been an ongoing effort in the gap junction
research community. Being a vertebrate homolog of innexins, it therefore
became logical to determine if pannexins exhibited similar characteristics to the
well studied gap junction proteins of vertebrates, connexins.

5

Figure 1.1 Evolutionary aspect of innexins, connexins and pannexins
Schematic representation of presence (+) and absence (-) of innexins,
connexins and pannexins in various taxonomic groups. Adapted from
Shestopalov and Panchin (2008).
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1.2 Human and murine pannexin genes
Amino acid sequence alignment of the three human pannexins members:
PANX1, PANX2 and PANX3, revealed 49-94% similarity with murine pannexins
[2]. While human pannexins are written in uppercase, murine pannexins are
represented by the Panx1, Panx2 and Panx3 nomenclature.
PANX1 located on human chromosome 11q14.3, contains five exons and four
introns and encodes a 426 amino acid protein (Accession number NP_056183)
with an expected molecular mass of 47.6 kDa [21]. On the other hand, murine
Panx1 is located on chromosome 9, and similar to human PANX1 encodes five
exons and four introns [21], generating a product of 426 amino acids (Accession
number NP_062355) with a molecular weight of ~45 kDa [25].
PANX2 located on human chromosome 22q13.31-13.33, contains 4 exons and
has two protein isoforms [21]. PANX2 isoform 1 contains 677 amino acids
(Accession number NP_443071), and isoform 2 contains 643 amino acids
(Accession number NP_001153772), with a predicted molecular mass of ~70
kDa [21]. The murine Panx2 is located on chromosome 15 and similar to the
human PANX2, contains 4 exons and encodes a protein product of 677 amino
acids (Accession number NP_001002005) with a molecular weight of ~80 kDa
[21]. Finally, the human PANX3 is similar to the murine Panx3, as they both
contain 4 exons and encodes a 392 amino acids long protein with a molecular
weight of ~44.7 kDa and ~43 kDa, respectively (human: Accession number
NP_443191; murine: Accession number NP_766042) [21]. While human PANX3
is located on 11q24.2, murine Panx3 is located on chromosome 9 [21].
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Interestingly, both the human and murine pannexin genes for Panx2 and Panx3
are located on shorter chromosome segments (less than 6 kb from first to last
exon) than Panx1 (more than 40 kb from first to last exon) [21]. Moreover, Panx1
and Panx3 are located on the same chromosomes in human and mouse, with a
separation of 30 Mb and 22 Mb, respectively, and share 41% identity and 59%
conservation at the primary structure level [21]. Given the overall similarity in the
exon-intron organization, chromosomal location, and the shared conservation at
the amino acid level, it is postulated that the close relationship of Panx1 and
Panx3 may have arisen from chromosomal duplication [21]. Furthermore, the
phylogenetic mapping of vertebrate pannexins revealed more divergence of
Panx1 from Panx2, suggesting unique roles for these family members [21]. Given
that Panx1 and Panx3 are more closely related to each other, this thesis will
predominantly focus on these two members of the pannexin family.

1.3 Diversity of pannexin expression
In addition to the human and mouse genomes, the expression of all three
pannexin members have now been identified in at least 5 more species including:
Rattus norvegicus (rat), Canis familaris (dog), Bos Taurus (cow), Danio rerio
(zebrafish) and Tetraodon nogrovirdis (puffer fish) [2]. Despite the vast interspecies distribution, pannexins are most well characterized in human and rodent
tissues, with Panx1 being the most studied member. The first studies relied on
detecting pannexins at only the transcript level due to the unavailability of highquality, custom-designed antibodies.
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1.3.1 Pannexin1
Northern blot analysis of human tissues revealed Panx1 expression in brain,
heart, skeletal muscle, skin, testis, ovary, placenta, thymus, prostate, lung, liver,
small intestine, pancreas, spleen, colon, blood endothelium and erythrocytes
[21]. In the central nervous system (CNS), Panx1 transcripts were detected in
cerebellum, cortex, lens (fiber cells), retina (retinal ganglion, amacrine and
horizontal

cells),

pyramidal

cells,

interneurons

of

the

neocortex

and

hippocampus, amygdale, substantia nigra, olfactory bulb, neurons and glial cells
[21, 24, 26-35]. Developmentally, a gradient of Panx1 expression was found in
mouse brain, such that higher levels were expressed during the embryonic
(E13.5-18) and postnatal stages with lower levels in the adult brain [30, 32].
Notably, our tissue survey using custom-designed affinity purified anti-Panx1
antibodies demonstrated a robust expression of Panx1 in the brain, with variable
levels of Panx1 in the lung, kidney, spleen, heart ventricle, skin and sources of
cartilage from ear and tail of a 3-week old mice [25]. More recently, Panx1
protein expression was also detected in the rodent cochlea, specifically in
supporting cells of the Organ of Corti, spiral limbus, cochlear lateral wall and
strial blood vessels [36].

1.3.2 Pannexin2
In comparison to Panx1, Panx2 mRNA was restricted to several areas of the
human adult brain including: cerebellum, cerebral cortex, medulla, occipital pole
frontal lobe, temporal lobe and putamen [21]. While Northern blot analysis
revealed higher levels of Panx2 transcript in the rodent brain, spinal cord and
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eyes, other tissues such as thyroid, kidney and liver also revealed some level of
Panx2 expression [26-28]. Interestingly, in-situ hybridization revealed coexpression of Panx2 with Panx1 in various regions of adult rat brain, such as
hippocampus, olfactory bulb, pyramidal cells, dentate gyrus, Purkinje cells of the
cerebellum, pyramidal cells and interneurons of the hippocampus and neocortex
[32]. Unlike Panx1, Panx2 transcript expression was low during prenatal
development of rat brain, and substantially increased in postnatal brains [32].
Recently, Panx2 protein expression was identified in the basal cells of the stria
vascularis and spiral ganglion neurons of the rat cochlear system [36].

1.3.3 Pannexin3
Based on expressed sequence tags, Panx3 was predicted to be present in
osteoblasts, synovial fibroblasts, whole joints of mouse paws, and cartilage from
the inner ear [21]. In addition, Panx3 transcript expression, albeit low, was also
detected in human hippocampus extracts [21]. Recently, Panx3 protein
expression was reported in murine cochlear bone [36], while in-situ hybridization
of

embryonic day 16.5 mice strongly revealed Panx3 expression in

prehypertrophic chondrocytes, perichondrium and osteoblasts [37]. Furthermore,
we demonstrated that while Panx3 protein exhibits two forms at ~43 kDa and ~70
kDa, when expressed in skin, cartilage, and ventricle, only the ~70 kDa species
is detected in lung, liver, kidney, thymus and spleen of a 3 week old mice [25]. It
is however yet to be determined if the occurrence of ~70 kDa species is due to a
splice variant or Panx3 dimerization.
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1.4 Pannexin family members share similar topology to
connexins
The discovery of pannexins led to further analysis of the protein topology using
multiple sequence alignment systems [2]. Connexins, innexins and pannexins all
share the same topology with four alpha-helical transmembrane (TM) domains,
two extracellular loops (EL), one intracellular loop (IL) and intracellular amino
(NT) and carboxy (CT) termini [1, 2, 21] (Figure 1.2). While primary sequence
homology does not exist between Panxs and Cxs, various motifs of Panxs and
Inxs share significant sequence homology [2]. Both Inxs and Panxs share two
cysteine residues in each of their EL domains (Figure 1.2), with the exception of
Drosophila Inx4 that has 3 pairs of cysteines [2, 38].
The two cysteine residues within the 1st EL are fully conserved between Panxs
and Inxs, with 37% identity and 58% amino acid similarity when flanked by 24
additional amino acids. However, only 1 of the 2 cysteine residues is conserved
in the 2nd EL of Panxs and Inxs [2]. Comparatively, the well characterized Cx
family member, Cx43, has 3 cysteine residues in each of its ELs [39] (Figure 1.2)
which is the same for all characterized connexins with the exception of Cx23,
which harbors 2 pairs of cysteines [40]. In the case of Cx43, and likely all other
family members, these cysteine residues are critical for forming intramolecular
disulfide linkages between ELs, such that when docked at the apposing plasma
membrane, each half of the GJ channel is stabilized by intermolecular hydrogen
bonds [41].
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Figure 1.2 Topology of innexins, connexins and pannexins
Panx1, Panx2 and Panx3 share similar topology of four transmembrane domains
(TM), two extracellular loops (EL), one intracellular loop (IL) and intracellular
amino (NT) and carboxy (CT) groups with innexins and Cx43. Pannexins and
innexins also share two cysteine residues in each of their ELs, while Cx43 has
three cysteine residues. Panx1 is glycosylated on the second EL, whereas Panx2
and Panx3 are glycosylated on the first EL.
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Interestingly, a signature sequence of all Inxs (YYQWV) is not conserved in
Panxs. However, this motif along with a 23 amino acid flanking region in Inxs
exhibits 39% identity and 61% similarity in TM2 of Panxs [2]. Additionaly, a
proline motif (correlated with conformation changes associated with channelgating in Cxs) is conserved in TM2 of Inxs and Panxs, and is found in relatively
the same position in Cxs [42].
While Inxs and Panxs contain two fully conserved cysteine residues in their CT
region, it is the NT domains that are better conserved [2]. All connexin members
posses almost the same length of intracellular NT domain with major differences
found in the length of the CT domain [43]. In contrast to Panx1 and Panx3,
Panx2 exhibits a very large CT domain (Figure 1.2) which is speculated to
convey unique functions to Panx2 regulation, targeting or macromolecular
interactions [2]. The regulatory role of the Cx43 CT domain is multifaceted. This
includes many interactions with scaffolding and cytoskeletal proteins [44] that
contribute to the overall size and number of gap junction plaques at the cell
surface [45] and the channel gating properties [46]. However, the role of the CT
domain in Panxs has yet to be investigated.

1.5 Pannexins and connexins form multimeric channels
Initial characterization of Panx1 oligomerization revealed that 6 subunits were
required for a channel formation [47]. The monomers of Panx1 resolved at ~4349 kDa, whereas the dimeric and hexameric configuration was detected at ~98
kDa and ~290 kDa, respectively [47]. While Panx1 and Cx43 channels share a
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hexameric configuration, this is quite different from the heptamers or octomers
reported for Panx2 [48].

On the other hand, the state of oligomerization for

Panx3 is currently unknown.

Distinct from Cx43, Panx1 forms a wider pore

channel [49] likely due to relatively longer ELs (~50-60 amino acids) than seen in
Cxs (~30 amino acids) [24] (Figure 1.2). Pannexin hexamers are termed
pannexons [47], following the nomenclature devised for connexins (as connexin
hexamers are termed connexons) [3, 4]. While ‘connexons’ are also referred as
‘hemi-channels’ (i.e. a structure constituting half of the channel), the term
‘pannexons’ primarily reflects the single-membrane channel. It is well established
that connexons from adjacent cells dock at the plasma membrane to form
intercellular channels, however, an ongoing effort continues in the field to deduce
if single membrane channels of pannexins also possess the capability to form
intercellular junctions [50].

1.6 Pannexins do not readily form intercellular channels
Currently, there are conflicting reports in the literature as to whether pannexins
are involved in direct intercellular communication. It was initially reported that
over-expression of Panx1 mRNA, but not Panx2 or Panx3, formed intercellular
channels, albeit, 24-48 hours after pairing Xenopus oocytes [26, 51, 52]. In a
parallel study, Boassa et al., [47] reported that while Panx1 intercellular
channels did not form resulting in a significant junctional conductance within 6
hours of oocytes pairing, the Cx46 formed robust intercellular channels within 1
hour [47]. Additional evidence of intercellular channel formation by Panx1 was
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derived from two independent studies using C6 glioma cells [53] and LNCaP
prostate cancer epithelial cells [54]. While these studies revealed the passing of
sulfurodamine 101 dye in C6 gliomas [53] and Ca2+ permeability in LNCaP
neighboring cells [54], they were performed under highly artificial conditions of
either bathing or perfusing the cells with chemical agents, thus questioning the
ability of pannexins to readily or efficiently form intercellular channels. A scrape
loading

assay

(a

commonly

used

technique

to

detect

intercellular

communication) conducted by Boassa et al., [47] further revealed the inability of
Panx1 to pass Lucifer yellow dye in communication-deficient Madin-Darby
Canine Kidney cells. This study was in line with our findings that revealed no
electrical coupling conductance in gap junction-deficient neuro-2A (N2A) cells
expressing either Panx1 or Panx3 [25]. Additional reports in erythrocytes [55] as
well as neuronal and glial cells [56] have also failed to provide evidence that
Panxs can in fact form gap junctions, thus providing further indication that the
pannexin family of proteins does not serve a role redundant to that of connexins
by readily forming intercellular channels.

1.7 Pannexins form functional non-junctional channels
It was first identified in 2003, that Panx1, but not Panx2, possesses the ability to
form non-junctional membrane channels, in single Xenopus oocytes [26]. The
unitary conductance of Panx1 single-membrane channels was determined to be
550 pS [57], which was approximately 200 pS larger than that of any of the
connexins [58]. Co-injections of Panx1 and Panx2 transcripts, revealed a ~15%
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reduction in the conductance of heterotypic channels (comprised of different
subunits), thus reflecting a dominant negative effect of Panx2 on Panx1 channel
function [26]. Since then, we have reported that all family members: Panx1,
Panx2 and Panx3 can form variable levels of single-membrane channels,
capable of dye uptake [59]. However, intermixing of Panx1 with Panx2, but not
Panx3, attenuated the channel function by lowering the incidence of dye uptake
[59]. While Panx1 channels can be activated by mechanical stimulation,
cytoplasmic Ca2+, membrane depolarization and extracellular ATP [49, 57, 6062]; its conductance is abolished by CO2-mediated cytoplasmic acidification [60],
negative feedback from ATP release [63], mimetic peptides [64] and channel
blockers such as carbenoxolone, probenecid and fluefenamic acid [65, Barbe,
2006 #3]. It is now well established that the activation of pannexin singlemembrane channels allows for cellular communication with the extracellular
environment to fulfill a diverse range of functions [50, 56, 60, 66, 67].

1.8 Physiological roles of pannexin single-membrane
channels
1.8.1 Paracrine signaling mediated by Panx1
Indirect communication between cells is typically mediated through activation of
single-membrane channels and releasing molecules such as ATP [68] into the
extracellular space.
Calcium waves: Ca2+ is a versatile, ubiquitously expressed second messenger
that can regulate several cellular responses [69]. Initiation of Ca2+ waves is
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mediated by the activation of ATP-sensitive purinergic receptors, P2Y and P2X
[70]. Binding of ATP to the membrane receptor increases inositol 1, 4, 5triphosphate, which in turn, releases Ca2+ from the ER stores. Once released,
Ca2+ activates single-membrane channels, leading to further release of ATP, and
propagation of signal to the neighboring cells [71]. Essential to this notion is the
fact that Panx1 has been shown to be a part of the P2X7 receptor complex,
necessary for ATP release [55, 72]. Furthermore, ATP-induced ATP release was
also reported when Panx1 channels were activated through P2Y receptors and
cytoplasmic Ca2+ [60], thus supporting the role of Panx1 in the initiation and
propagation of regenerative Ca2+ signaling.
Vasodilation:

Release of ATP from erythrocytes occurs during stress and

hypoxic conditions [73].

It was recently discovered that erythrocytes

endogenously express Panx1, and mechano-sensitive activation of Panx1
channels regulate ATP release [55]. It is hypothesized that under conditions of
stress, activation of Panx1 channels control blood flow, by releasing ATP from
red blood cells, and initiating Ca2+ wave propagation through stimulation of
purinergic receptors on the endothelial cells [55]. Elevation of Ca2+ subsequently
releases NO onto the smooth muscle, leading to vasodilation [55].
Taste sensation: Taste buds are comprised of two distinct population of cells,
some that express taste receptors (receptor cells), and others that contain
synapses (presynaptic cells) [74]. It has been reported that Panx1 is expressed
in the receptor cells, and upon taste stimulation, ATP is released through Panx1
single-membrane channels [65, 74]. Once released in the extracellular medium,
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ATP stimulates P2 receptors of the presynaptic cells to release serotonin (5-HT)
[65, 74], thereby providing a mechanism for cell-cell signaling and information
processing within taste bud.
Airway defense: Airway epithelium provides a defense mechanism by controlling
mucociliary clearance, which depends on maintaining adequate airway surface
liquid volume and ciliary activity [75].

In the differentiated human airway

epithelium cells, expression of Panx1 single-membrane channels in the apical
region has been linked to ATP release under hypotonic stress [75].

Panx1-

evoked ATP release is proposed to be crucial for regulating the ciliary beat
frequency and surface liquid volume for mucous clearance [75].

1.8.2 Intracellular responses mediated by Panx1
Immune response: Interaction of Panx1 with P2X7 receptors elicits an immune
response by releasing the pro-inflammatory cytokine interleukin (IL)-1 β, in
response to receptor stimulation by ATP followed by a subsequent activation of
caspase-1 [49]. Panx1 is also reported to trigger the Toll-like receptorindependent inflammasome (comprising cryopyrin), based on recognition of
bacterial molecules passing from endosomes to cytosol [76]. Furthermore, P2X7mediated activation of Panx1 channel is potentiated by high extracellular K+
levels in neuronal/astrocytic inflammasomes [77].
Tumorigenesis: Exogenous expression of Panx1 has been linked to tumorsuppressive properties in C6 gliomas [53]. In the presence of Panx1, C6 gliomas
exhibit a flattened morphology and a reduction in proliferation, motility,
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anchorage-independent growth [53]. In addition, injection of Panx1 expressing
cells in nude mice reduced the in vivo tumor growth [53]. Taken together, it is
suggested that Panx1 plays a role as a tumor suppressor.
Ischemic cell death and Epileptic seizure: The rapid decrease of O2 and glucose
in mouse hippocampal pyramidal neurons has been associated with the opening
of Panx1 single-membrane channels that leads to conductance of large currents
[78]. This, in turn, causes a profound ionic dysregulation, thereby leading to
neuronal death [78]. In addition, the N-methyl-D-aspartate receptor-based
opening of Panx1 channels leads to epileptiform seizure activities in pyramidal
neurons [66], further supporting the importance of precise regulation of Panx1
channel openings.
Apoptosis: Panx1 forms the pore unit of the P2X7 death complex [72]. The coexpression of Panx1 with P2X7 receptor revealed ATP-induced zeiosis in
Xenopus oocytes, which was not observed upon the injection of Panx1 transcript
alone or together with P2Y receptor [60, 72]. These results suggest that although
activation of purinergic P2Y receptor can mediate Panx1 currents, the specific
cell death signaling is through interaction with ionotropic P2X7 receptor. Quite
recently, Panx1 channels have been documented to mediate the release of
nucleotide signals from apoptotic cells for the recruitment of activated monocytes
[79]. In this situation, Panx1 channels gets activated by caspases which cleave
Panx1 and opens the channel for ATP and UTP release as a “find me” signal to
attract phagocytes [79].
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Keratinocyte differentiation: We have previously shown that ectopically
expressed Panx1 reduces the proliferation rate of rat epidermal keratinocytes
(REKs), however, it does not significantly alter their migratory properties [67].
Furthermore, over-expression of Panx1 in organotypic cultures (generated from
monolayer REKs) disrupts the overall architecture of the epidermis, reduces the
thickness of vital layer (likely stratum spinosum and granulosum) and re-localizes
the basal cell marker, cytokeratin 14, throughout the vital layer [67], thus, arguing
for an adequate expression of Panx1 in maintaining keratinocyte differentiation.

1.8.3 Intracellular responses mediated by Panx3
Keratinocyte and Chondrocyte differentiation: In contrast to Panx1, much less is
known about the channel capabilities of Panx3. We have shown that, similar to
Panx1, Panx3 also reduces the proliferation of REKs without altering its migration
rates [67]. However, unlike Panx1, Panx3 maintains the integrity of the
organotypic epidermis and keratinocyte differentiation upon its over-expression
[67]. In addition, Panx3 expression in cartilage has recently been associated with
chondrocyte differentiation [37]. Specifically, Panx3 promotes ATP release into
the extracellular medium (likely by the action of Panx3 single membrane
channels), and reduces the parathyroid hormone-mediated proliferation of
chondrocytes by decreasing cAMP levels and inhibiting phosphorylation of CREB
[37]. Thus, these results support a role for Panx3 in switching the fate of
chondrocytes from proliferation to differentiation.
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1.9 Distinct from Cx43, Panx1 and Panx3 are glycosylated
Consensus site analysis of Panx1 and Panx3 polypeptide sequences followed by
experimental investigation revealed that glycosylation occurs at asparagine 254
in the second extracellular loop of Panx1 (Figure1.2), and at asparagine 71 in the
first extracellular loop of Panx3 [25]. Treatment with N-glycosidase F, revealed
the glycosylation status of Panx1 [25, 47, 59] and Panx3 [25, 59]. Three distinct
glycosylation species of Panx1 and Panx3 were revealed: the non glycosylated
form that constitutes the core protein- Gly0 (resolves at ~37 kD for Panx1 and
~30 kD for Panx3), the predominant ER resident high mannose form- Gly1
(resolves at ~42-43 kD for Panx1 and ~43 kD for Panx3) and the complex
glycosylated form that is fully processed- Gly2 (resolves at ~48 kD for Panx1 and
at ~44-45 kD for Panx3). Glycosylation of pannexins is a post-translational
modification that is not found on any connexin, including Cx43. Instead, the
multiple banding profile of Cx43 detected by immunoblotting is due to differential
states of phosphorylation [80]. Although both Panx1 and Panx3 encode several
consensus sites for phosphorylation [25], alkaline phosphatase treatment did not
change the protein banding pattern for either Panx1 or Panx3, unlike Cx43 [25].
Nevertheless it remains possible that Panxs could serve as a substrate for
phosphorylation events without causing any shift in the banding profile.
The extended carbohydrate modifications on the ELs of pannexins have been
reported to prevent the close docking of single-membrane channels at cell-cell
appositions, in contrast to the connexons which are never glycosylated. Electron
micrographs of Panx1 in the areas of apposing cells revealed intercellular
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spacing of 20-50 nm, which is quite distinct from the 2-4 nm spacing seen in
Cx43-based gap junctions [47]. The glycosylation status of Panxs has also been
proposed to be mechanistically inhibitory to gap junction formation. This notion is
based on the report where removal of all cell surface glycan chains from rat
Panx1 as well as all other cell surface glycoproteins increased the junctional
conductance in Xenopus oocytes [81]. Interestingly, the GJ coupling did not
occur until 6 hours post pairing, which is greatly delayed from paired Oocytes
that express connexins [47, 81].
Glycosylation of Panx1 and Panx3 is important for proper trafficking to the cell
surface. This conclusion is based on reduced [25] or absent cell surface
localization [47] of the glycosylation-deficient mutants Panx1N254Q or Panx3N71Q.
Our recent data has shown that a subpopulation of both the N-glycosylation
deficient mutants of Panx1 and Panx3 that do reach the cell surface are capable
of forming functional single membrane channels [59],

thus suggesting that

glycosylation of pannexins mediates their cell surface trafficking, without
impairing the ability to assemble into functional channels. Overall, the distinct
post-translational modification of Panx1 and Panx3 in comparison to Cx43
separates the pannexin family from the better understood connexin family of
proteins. While the life cycle aspects of Cx43 are well characterized, our
knowledge of trafficking events regulating the Panx1 and Panx3 function remains
poor.

22

1.10 The life cycle of Cx43-from biogenesis to degradation
1.10.1 Biogenesis of Cx43
Cx43 has a relatively short half life of approximately 1-3 hours [82]. As a result,
gap junction channels composed of Cx43 are continually being transported to
and removed from the plasma membrane. Being an integral membrane protein,
Cx43 becomes co-translationally inserted into the ER membrane prior to
oligomerization into connexons [13, 83]. Although several connexins have been
reported to oligomerize in the ER [84-86], this is not the case for Cx43. Instead,
Cx43 exist in a monomeric form after exiting the ER, and undergoes
oligomerization in the trans-Golgi network prior to the cell surface trafficking [87].

1.10.2 Transport of Cx43 to the plasma membrane
Time-lapse imaging of the GFP-tagged Cx43 has revealed its delivery to the
plasma membrane in pleiomorphic vesicles and tubular extensions, originating
from the distal end of the Golgi apparatus [88]. Transport of Cx43 is also
facilitated in part by microtubules. This understanding is based on the fact that
Cx43 gap junction plaques failed to readily regenerate in the presence of
nocodazole-induced depolymerized microtubules [88]. Interestingly, other reports
suggest that neither microfilaments nor microtubules are an absolute requirement
for the assembly of gap junctions; however, intact microtubules are necessary for
the enhanced growth of gap junctions and Cx43 transport to the plasma
membrane [89]. The targeting of Cx43 to specific cell surface micro-domains,
however, remains relatively unclear with some evidence supporting a role for
adherens-based junctions in the formation of gap junctions [90, 91].
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Once at the cell surface, connexons were originally proposed to exist in a gatedclosed state to avoid unwanted exchange of small molecules with the
extracellular environment [13]. However, this notion is currently evolving as
several lines of evidence supports the role of unpaired connexons, otherwise
called hemichannels, in non-junctional plasma membranes for the intercellular
communication through paracrine signaling [92, 93].

1.10.3 Assembly of Cx43 gap junctions at the cell
surface
At the cell surface, connexons from two adjacent cells dock to form gap junction
channels that tightly cluster into gap junction plaques [13]. Studies using
tetracysteine and GFP-tagged Cx43 supported a model in which new gap
junctions formed at the outer edge of the plaques, with mature channels
coalescing at the center of the plaques [94, 95]. Cx43 was documented to cluster
into gap junction plaques through lateral movements [88]. Fluorescence recovery
after photobleaching (FRAP) revealed two states of Cx43 lateral mobility, high
and low [96]. The differential rates of Cx43 mobility was proposed to be either
due to scaffolding with binding partners, and/or acquiring different states of
channel packing-ranging from loose (new) to crystalline (mature) structures [96].
Electron microscopy images of Cx43 containing fragments budding from the
inner segment of gap junction plaques further support the mature aspects of the
gap junction being destined for internalization and degradation [94].
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1.10.4 Internalization and degradation of Cx43
Several electron microscopic studies have reported the internalization of
connexons into one of the two neighboring cells in the forms of doublemembrane structures [97-100], recently coined connexosomes [13].

Micro-

injection studies with anti-Cx43 antibody, together with rapid time-lapse imaging
revealed connexosomes to originate from pre-existing gap junction plaques and
internalize in one of the two adjacent cells [101]. Furthermore, a close
association of Cx43 double-membrane structures to clathrin-coated pits and actin
cytoskeleton [102-104] suggests additional mechanisms may be involved in
Cx43- gap junction internalization.
Once internalized, degradation of Cx43 is mediated by both lysosomes and
proteasomes [105, 106]. Evidence suggests that mono-ubiquitination of Cx43
serves as an internalization cue, whereas poly-ubiquitination directs it to the
lysosomes [107]. Alternatively, it is hypothesized that proteasomal-mediated
degradation of Cx43 might be correlated with ER-associated degradation (ERAD)
of mis-folded proteins, while lysosomes function to degrade Cx43 removed from
the plasma membrane [13].
Although Cx43 is well characterized from biogenesis to degradation, an in-depth
knowledge of the life cycle of pannexins remains obscure.
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1.11 Rationale, Hypothesis and Objectives of the Thesis
1.11.1 Rationale
Ever since the discovery of pannexins, considerable focus has been given
towards understanding the function of these channels and their physiological
roles; however, trafficking events that regulate the overall function of pannexins
are not fully understood. Although pannexins and connexins were reported to
share structural similarities [1, 108], it was not clear if pannexins exhibit
characteristics similar to connexins in terms of their plasma membrane delivery
and localization, cell surface mobility dynamics, interplay with the cytoskeletal
network and pathways governing their turnover and degradation. Therefore, we
paralleled our study to the well-characterized life cycle of Cx43. For our studies
we mainly utilized Cx43 positive BICR-M1Rk, (rat mammary tumor) cell line as
these cells are devoid of Panx1 and Panx3 expression, and have previously
proven to be an excellent reference model for characterizing the trafficking,
assembly and turnover of Cx43 [96, 109]. BICR-M1Rk cells can also be readily
engineered to express either Panx1 or Panx3.

1.11.2 Hypothesis
I hypothesize that in comparison to Cx43, Panx1 and Panx3 exhibit distinct
subcellular distributions, cell surface motilities and cytoskeletal dependencies;
while Panx1 is further governed by unique turnover dynamics and mechanistic
pathways that lead to its internalization and degradation.
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1.11.3 Objectives (Figure 1.3)
Objective 1 (Chapter 2)

To characterize the subcellular distribution of Panx1

and Panx3, to identify the secretory pathway involved in Panx1 and Panx3 cell
surface trafficking, to analyze the mobility dynamics of GFP-tagged Panx1 and
Panx3 at the cell surface and to assess the role of the cytoskeleton in Panx1
trafficking and cell surface dynamics.
Objective 2 (Chapter 3)

To identify the role of the carboxyl terminal tail in

Panx1 trafficking and homomeric interactions.
Objective 3 (Chapter 4)
degradation

To explore the pathways for Panx1 internalization and
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Figure 1.3 Schematic representation of the aims addressed in the study
Aim#1: To characterize the subcellular distribution profile of Panx1 and Panx3,
to identify the secretory pathway involved in Panx1 and Panx3 cell surface
trafficking, to analyze the mobility dynamics of GFP-tagged Panx1 and Panx3 at
the cell surface to assess the role of the cytoskeleton in Panx1 trafficking and cell
surface dynamics. Aim #2: To identify the role of carboxyl terminal tail in Panx1
trafficking and homomeric interactions. Aim #3: To explore pathways for Panx1
internalization and degradation.
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CHAPTER 2: Pannexin1 and Pannexin3 Delivery, Cell
Surface Dynamics, and Cytoskeletal Interactions

2.0 OVERVIEW

This study was designed to determine if Panx1 and Panx3 exhibit unique
characteristics (trafficking, cell surface dynamics and interplay with the
cytoskeletal network) or are similar to the well studied gap junction protein, Cx43.

_____________________
This chapter has been published:
Bhalla-Gehi, Ruchi ; Penuela, Silvia ; Churko, Jared M ; Shao, Qing ;
Laird, Dale W; Pannexin1 and pannexin3 delivery, cell surface
dynamics, and cytoskeletal interactions. J Biol Chem, 2010. 285(12): p. 9147-60.
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2.1

INTRODUCTION

The pannexin family is a new class of integral membrane glycoproteins that have
been identified to share sequence homology to the invertebrate gap junction
proteins, innexins [1]. Unlike the connexin family that is comprised of 21
members [110], both the human and mouse genomes contain only three
pannexin-encoding genes (Panx1, Panx2 and Panx3) [1]. Although connexins
and pannexins exhibit no sequence homology, pannexins are predicted to share
similar topology to connexins which includes four transmembrane domains, two
extracellular loops, a cytoplasmic loop and intracellular amino and carboxy
terminals [21, 25, 47]. Our previous study has shown that ectopically expressed
Panx1 and Panx3 are capable of trafficking to normal rat kidney (NRK) cell
surfaces; however, their distribution profile at cell-cell interfaces is not typically
clustered or punctate as seen for Cx43 [25]. Consistently, electron micrographs
of Panx1 over-expressing Madin-Darby Canine Kidney cells also revealed
dispersed Panx1 localization at the plasma membrane with no evidence of gap
junction plaques [47].
Cx43 has a relatively short half-life of approximately 1-3 hours [82]. As a result,
Cx43 subunits assembled into connexons within the trans Golgi network [87] are
constantly being transported to and removed from the plasma membrane [88].
Recent reports provide evidence that although Panx1 appears to form similar
hexameric channel units defined as pannexons [47], they exhibit slower turnover
dynamics in comparison to Cx43, as assessed by the use of pharmacological
blockers of protein synthesis and protein trafficking [25, 47]. Functionally, most
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studies support the premise that pannexins, in particular Panx1, form single
membrane channels [25, 47, 50, 71, 111, 112], while far less evidence supports
the notion that they also can form intercellular channels [26, 53].
The delivery of Cx43 for the assembly of functional channels at the cell surface
has been extensively studied using fluorescent protein and epitope tags [94, 96].
Cx43-GFP has been shown to exhibit similar distribution and functional
characteristics as its untagged counterpart, when assessed by dye permeability
and electrical conductance [88, 113]. Likewise, GFP tagging of the carboxyl
terminal tail of Panx1 did not significantly alter the localization profile of Panx1 in
NRK cells [25]. However, a recent electrical conductance assessment provided
evidence that mouse Panx1-GFP exhibits reduced channel function when
expressed in human embryonic cells (HEK) 293 cells [114], suggesting that its
functional state is somewhat impaired but not completely eliminated by the GFP
tag. In other studies, untagged and tetracysteine-tagged Panx1 exhibited
comparable capabilities in rescuing the trafficking of the glycosylation-defective
mutant of Panx1 in Madine-Darby canine kidney cells [81]. Collectively, these
studies would suggest that the trafficking and life cycle properties of Panx1 can
be assessed by GFP tagging approaches in conjunction with real-time dynamic
imaging.
It has been previously established through a number of studies using both
untagged and GFP-tagged Cx43 that the delivery and regeneration of Cx43 gap
junction plaques is facilitated by microtubules and requires a fully functional
secretory pathway [88, 89, 95]. Other studies using rapid time-lapse imaging of
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GFP and tetracysteine tagged Cx43 have shown that Cx43 is delivered in 100150 nanometer vesicles that coalesce laterally into the pre-existing gap junction
plaques [94, 115]. However, the delivery of pannexins to the cell surface, their
dynamic organization at specific cell surface micro-domains, and their
dependency on an intact cytoskeletal network, have yet to be investigated.
The life-cycle of Cx43 is governed, in part, by many direct and indirect binding
partners [13, 44, 116], while pannexin binding partners are only beginning to be
identified with some evidence to support Panx1 interaction with a protein subunit
of the voltage-dependent potassium channel [117] and regulatory cross-talk with
P2X7 receptors [49, 111]. In the present study we further expand on a very
limited number of pannexin binding proteins by identifying actin as a specific
Panx1 binding protein.
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2.2 EXPERIMENTAL PROCEDURES
2.2.1 Cell Culture and Reagents
BICR-M1Rk cells originally derived from a rat mammary tumor, HEK-293T, NRK
and REK (rat keratinocytes) cells were cultured in high glucose DMEM
(Invitrogen, Burlington, ON, Canada), supplemented with 10% fetal bovine
serum, 100 units/ml penicillin, 100 µg/ml streptomycin, and 2 mM L-glutamine (all
from Invitrogen, Burlington, ON, Canada). B16-BL6 murine melanoma cells were
kindly provided by Dr. Moulay A. Alaoui-Jamali-(Department of Medicine and
Oncology, McGill University; Montreal, Canada) and cultured as previously
described [118]. Trypsin (0.25%, 1mM EDTA), Opti-MEM1 media and
Lipofectamine 2000 were purchased from Invitrogen. Brefeldin-A (BFA),
nocodazole and cytochalasin B were purchased from Sigma-Aldrich (Oakville,
ON, Canada).

2.2.2 Expression Constructs of Mouse Panx1, Panx2,
and Panx3 and Engineering of the GST-Panx1
Carboxyl domain
Untagged and GFP-tagged expression constructs encoding full length mouse
Panx1 and Panx3 were previously described [25], and correspond to current
NCBI reference sequence encoding 426 amino acids for Panx1 (NP_062355)
and 392 amino acids for Panx3 (NP_766042).
As previously described, Panx2 was originally cloned from mouse brain and the
purified PCR product was inserted into the EcoR1-Sal1 site of pEGFP-N1 vector
(Clonetech, CA) to generate the untagged Panx2 [59]. The sequence was
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confirmed to encode 677 amino acids according to RefSeq. Furthermore, Panx2
cDNA was amplified using forward primer: 5’- CCCAAGCTTATGCACCACCTC to
create a HindIII site and 5’- GGCGACCGGTCCAAACTCCACA to create a AgeI
site at the 5' and 3' ends of Panx2, respectively. PCR products and the vector
pEGFP-N1 (Clonetech, Palo Alto, CA) were digested with HindIII and Age1,
ligated and clones were selected. GFP was fused in frame to the carboxyl
terminus of Panx 2 with the addition of a five-amino acid polylinker
(GGACCGGTCGCCACC) and validated by sequencing.
Panx1 carboxy tail primers (Forward 5’- CTAGGATTCCGGCAGAAAACGGAC,
Reverse 5’- CGAGTCGACTTAGCAGGACGGATT), with flanking sites for BamHI
and SalI amplifying the Panx1 carboxy tail sequence (corresponding to amino
acid 299-426), were created. This sequence was ligated into the pGEX-6P-3
GST vector and transformed into BL21 bacteria.

Batch purification using

Sepharose 4B was performed as described in GST Gene Fusion System manual
with some modifications (GE Healthcare, Buckinghamshire, UK). A single BL21
clone transformed with either GST alone or GST-Panx1 carboxyl tail was grown
to absorbance (600nm) of 1 and was induced by the addition of 0.5 mM isopropyl βD-1-thiogalactopyranoside. A total of 500 mL of either GST or GST-Panx1
carboxy tail bacterial culture was shaken overnight at room temperature. The
next day purification was performed using 400 µL of 50% sepharose slurry,
washed in PBS seven times and stored at 4oC for the co-sedimentation assays.
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2.2.3 Transfection and Engineering of Stable Cell Lines
DsRed tagged Sar1WT and Sar1H79G cDNA constructs were previously described
[88] and used for transfection into BICR-M1Rk cells engineered to express Panx1
or Panx3. Briefly, BICR-M1Rk cells were grown overnight to 50-70% confluency
on glass coverslips and transfected in Opti-MEM1 media containing 4 μL of
Lipofectamine 2000 and 1 µg of Panx1 or 3 µg of Panx3 plasmid DNA together
with 2 µg of Sar1WT or Sar1H79G expression constructs.
Panx1-GFP cDNA construct was previously described (5) and used to transfect
BICR-M1Rk cells stably expressing untagged Panx1, and B16-BL6 cells. Cells
were grown overnight to 50-70% confluency on 35mm glass bottom dishes and
transfected in Opti-MEM1 media containing 1.5 μL of Lipofectamine 2000 and 1.5
µg of Panx1-GFP plasmid DNA for 4 hours at 37°C.
For Panx3 and Panx3-GFP co-transfections: BICR-M1Rk cells were grown
overnight to 20-30% confluency on 35mm glass bottom dishes and transfected in
Opti-MEM1 media containing 4 μL of Lipofectamine 2000 and 3 μg of Panx3
together with 1.5 μg of Panx3-GFP plasmid DNA. Opti-MEM1 media was
replaced with complete culture media 4 hours after transfection at 37 ˚C.
For Panx2 and Panx2-GFP expression: BICR-M1Rk cells grown overnight to 5070% confluency on glass coverslips were transfected in Opti-MEM1 media
containing 3 μL of Lipofectamine 2000 and 1.5 μg of Panx2 or 1.5 μg of Panx2GFP plasmid DNA. For co-transfection of Panx2 with Panx2-GFP 0.75 μg of
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each plasmid DNA was used in Opti-MEM1 media containing 3 μL of
Lipofectamine 2000.
Full length constructs encoding mouse Panx1, Panx1-GFP and Panx3 were
inserted into the AP-2 retroviral vector and transfected into the 293GPG
packaging cell line as described earlier by Qin et al. [119]. Following transfection,
replication-defective retroviral supernatants were collected and filtered through a
0.45 μm filter (Pall Gelman Laboratories, Ann Arbor, MI). BICR-M1Rk cells
expressing Cx43-GFP were engineered to stably express Panx1 and Panx3 by
following a previously described protocol [119]. Retrovirus encoding Panx1-GFP
was also used to stably express GFP-tagged Panx1 in BICR-M1Rk cells.

2.2.4 Treatments with pharmacological reagents
Panx1 and Panx3 over-expressing BICR-M1Rk cells were treated with 5μg/mL of
BFA for 19 hours at 37
˚C, and cell lysates were collected and subjected to
immunoblotting. For elucidating the role of cytoskeletal elements in pannexin
trafficking, Panx1-GFP expressing cells were treated with 10μM nocodazole or
2.5

μg/mL

cytochalasin

B

for

90

minutes
˚C andat fixed
37

for

immunocytochemistry. For fluorescence recovery after photobleaching (FRAP)
studies, Panx1-GFP expressing cells were pre-treated with cytoskeletal inhibitors
for 90 minutes prior to imaging up to 3-4 hours in presence of these same
inhibitors.
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2.2.5 Immunocytochemistry
Cells were immunolabeled as previously described [25]. Briefly, cells grown on
glass coverslips were fixed using ice-cold 80% methanol and 20% acetone for 20
minutes at 4˚C. Cytochalasin B-treated cells were fixed using 3.7% formaldehyde
for 30 minutes at room temperature and permeabilized for 45 minutes in a 1%
blocking solution (Bovine Serum Albumin-(BSA; Sigma)) containing 0.1% TritonX-100. Cells were incubated with a 500-fold dilution of polyclonal anti-Cx43
antibody (Sigma), a 100 fold dilution of polyclonal anti-GPP130 antibody
(Convance),

polyclonal

anti-Panx2

antibody

(Zymed

Laboratories,

San

Francisco, CA) or monoclonal anti-tubulin antibody (Convance) for 1 hour at
room temperature. Affinity-purified polyclonal Panx1 and Panx3 antibodies were
used at a concentration of 2 μg/mL. F-actin was localized using a 200 fold
dilution of rhodamine phalloidin (Invitrogen). Cells were incubated in goat antirabbit antibody conjugated to Texas Red or fluorescein isothiocyanate (FITC)
(1:100, Jackson Laboratories, Westgrove, PA) or a goat anti-mouse antibody
conjugated to Texas Red (1:100, Jackson Laboratory). Cells were rinsed with
PBS and nuclei were stained with Hoechst 33342 and mounted. Immunolabeled
cells were imaged using a 63x oil objective lens mounted on a Zeiss LSM 510
META (Zeiss, Toronto, ON) system.

2.2.6 Immunoblotting and Co-immunoprecipitation
Cell lysates from BICR-M1Rk cells transiently co-transfected with Sar1 and Panx1
or Panx3 cDNA constructs, and BFA-treated cells were collected using a lysis
buffer containing 1% Triton-X-100, 10 mM Tris, 150 mM NaCl, 1 mM EDTA, 1
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mM EGTA, 0.5% NP-40, 100 mM sodium fluoride and 100 mM sodium
orthovanadate and a protease inhibitor tablet (one tablet per 10 mL buffer;
Roche, Laval, QC), pH 7.4. Protein concentrations were measured using a BCA
protein determination kit (Pierce). In total, 20-30 µg of protein was resolved using
10% SDS-PAGE and transferred to nitrocellulose membrane (Pall Life Sciences,
NY). Nitrocellulose membranes were blocked in Licor blocking solution (Lincoln,
NE) or 3% BSA solution, and probed overnight with polyclonal affinity purified
anti-Panx1 or anti-Panx3 antibodies (0.2 µg/mL) at 4̊C. Monoclonal anti -β-actin
antibody (1:5000, Sigma) was used to assess gel loading. Detection of primary
antibody binding was performed by using mouse IgG IR dye 800 (Rockland
Immunochemicals, PA) and rabbit IgG Alexa 680 (Invitrogen) with Odyssey
infrared imaging system (Licor).
For co-immunoprecipitation experiments, 1 mg of protein lysates from WT, Panx1
and Panx1-GFP over-expressing BICR-M1Rk cells were incubated overnight at
4°C in the lysis buffer (1% Triton-X-100, 10 mM Tris, 150 mM NaCl, 1 mM EDTA,
1 mM EGTA, 0.5% NP-40, 1 mM sodium fluoride and 1mM sodium
orthovanadate containing 10 µg/mL of anti-Panx1 antibody. The antibody
complex was pulled down with 30 µl of pre-cleaned protein A-sepharose beads
(in PBS) for 2 hours on the rocker at 4°C. The antibody-bead complex was
centrifuged at 4500 RPM at 4°C for 2 minutes and supernatant was aspirated.
Unbound nonspecific protein was separated from bound proteins by washing
three times with 500 µL of lysis buffer, and the bound complex was detached by
boiling for 5 minutes in 30 µL of 2x Laemmli loading sample buffer containing β–
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mercaptoethanol. Samples were resolved by 10% SDS-PAGE and transferred to
nitrocellulose membranes which were probed with anti-Panx1 and anti-β-actin
antibodies.

2.2.7 FRAP analysis
To assess Panx1 or Panx3 dynamics at the cell surface, BICR-M1Rk cells
expressing Panx1-GFP alone or in combination with the untagged, Panx1, or
Panx3-GFP together with Panx3, were cultured on 35 mm glass bottom dishes
and subjected to FRAP. B16-BL6 cells expressing Panx1-GFP were also subject
to FRAP analysis. Rapid time-lapse imaging was performed on a Zeiss LSM 510
META to quantify the movement of Panx1-GFP into the bleached region of
interest (ROI), as previously described [96]. Briefly, glass bottom dishes were
placed in an environmentally-controlled chamber and ROIs representing the
various plasma membrane domains were selected and photo-bleached using
scan iterations at 488 nm with 100% laser strength. Images were acquired ~2-5
seconds apart for up to 60 seconds with 0.9% laser strength, to avoid further
photobleaching. Fluorescence intensities within ROIs were quantified as
previously described [96]. Briefly, fluorescence recovery was recorded: before
photobleaching, immediately upon completion of photobleaching (t was set to 0
seconds), and post bleaching at the following time intervals (15, 25, 50 and 60
seconds). Post-bleach intensities were corrected and normalized for any residual
fluorescence, and the recoverable fraction of Panx1-GFP or Panx3-GFP was
calculated using FNt= (Ft – F0)/ (Fi - F0) as previously described [120]; where FNt =
normalized fluorescence at a t time point; Ft = fluorescence intensity within ROI at
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t seconds post photo-bleach; F0 = fluorescence intensity upon photo-bleaching at
t = 0 and Fi = fluorescence intensity prior to photobleaching. All FRAP
experiments were repeated 3 times for each experimental set, with each set
containing multiple ROIs at t = 15, 25, 50 and 60 seconds. FNt values from
replicates of each experimental set were combined and a non-linear regression
analysis was performed to obtain a curve of best fit using GraphPad Prism
software (San Diego, CA). To compare the mobility dynamics of Panx1-GFP or
Panx3-GFP in various plasma membrane domains, a one-way ANOVA followed
by Tukey’s multiple comparison tests were performed. For comparisons between
untreated versus nocodazole and cytochalasin B treated experimental sets, t
tests were performed using GraphPad Prism software.

2.2.8 Vesicle Movement
Panx1-GFP containing vesicles were analyzed by measuring the total distance
traveled of vesicles that remained in confocal plane of focus for the duration of
the analysis. Vesicles of ~0.5-0.8 μm in diameter were monitored by 1.8 second
interval image scans for a total period of 8.8 seconds. (n= 18-20, over 4
independent repeats).

2.2.9 Actin co-sedimentation assays
Muscle actin (Cytoskeleton Inc., Denver, CO) was resuspended in buffer (5 mM
Tris-HCl pH 8.0, 0.2 mM CaCl2) to a concentration of 1 mg/mL in 250 µl on ice for
30 min. 25 µLs of 10X actin polymerization buffer (500 mM KCl, 20 mM MgCl2,
10 mM ATP, 100 mM Tris pH 7.5) was added to the monomeric actin and
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incubated at room temperature for 1h (F-actin stock at 23 µM). Protein samples
of BSA, GST, Panx1 C-tail and GST tagged Panx1 C-tail were centrifuged at
150,000 x g for 1 h at 4 ºC. Supernatants were collected and placed on ice. For
co-sedimentation assays, a GST fusion protein containing the C-tail of mouse
Panx1 was used, either as a fusion protein after elution from the sepharose
beads or after cleavage of the Panx1 C-tail from the fusion protein using
PreScission Protease (GE Healthcare, Buckinghamshire, UK) for 16 h at 4 ºC, as
per manufacturer's instructions. Following the Cytoskeleton Inc. protocol for actin
binding protein assays, 50 µL samples were prepared with either F-actin alone,
GST protein with or without F-actin, BSA (negative control) plus F-actin, and
Panx1 C-tail or GST fusion protein with or without F-actin.

Samples were

incubated at room temperature for 30 min, followed by centrifugation at 150,000
x g for 1.5 h at 24 ºC. Supernatants were carefully removed and mixed with 10
µL 4X Laemmli reducing-sample buffer. The pellets were resuspended in 30 µL
of double-distilled water and mixed with 30 µL of 2X Laemmli buffer. Equal
volumes of resuspended pellets and supernatants were run in duplicate on 10%
SDS-PAGE. Gels containing samples were either stained overnight with SyproRuby Protein gel stain (Invitrogen) or transferred onto nitrocellulose membranes
using an iBlot apparatus for dry transfer (Invitrogen). Sypro-Ruby stained gels
were de-stained and exposed to UV for visualization of the major bands.
Nitrocellulose membranes were incubated overnight with primary anti-Panx1
antibodies, washed, and probed with Alexa-680 anti-rabbit secondary for
detection of Panx1 bands with a LiCor scanner as described previously [25].

41

2.2.10 Biotinylation assays
BICR-M1Rk cells grown on 100 mm dishes were transiently transfected with 5-10
µg of Panx3-GFP encoding cDNA constructs, and 48 hours post transfection,
cells expressing Panx3-GFP were subjected to biotinylation treatment on ice as
previously described [25]. Cells were incubated in PBS or with cold PBS
containing EZ-link Sulfo NHS-LC-biotin (0.5 mg/mL; Pierce Biotechnology) for 20
min at 4oC. Control and biotin-treated cells were washed and incubated in 100
mM glycine buffer for 15 min at 4oC to quench the biotin. Cells were then lysed
with SDS lysis buffer (1% Triton X-100 and 0.1% SDS in PBS) and protein
concentrations were measured using a BCA protein determination kit (Pierce). In
total, 1000 µg of protein from control and biotin-treated cell lysates were rocked
overnight at 4oC in the presence of 50 μL of neutravidin-agarose beads (Pierce
Biotechnology). Beads were washed three times with immunoprecipitation lysis
buffer (IP) (150 mM NaCl, 10 mM Tris-HCl, pH 7.4, 1 mM EDTA, 0.5% NP-40,
and 1% Triton X-100) containing 1 mM NaF and 1 mM Na3VO4; and once with
PBS containing 1 mM NaF and 1 mM Na3VO4. The beads were air dried and
resuspended in 50 μL of 2x Laemmli loading sample buffer containing β–
mercaptoethanol before boiling for 5 minutes. As a lysate control, 40 μg of total
protein from control and biotin samples was also resolved by SDS-PAGE and
transferred to nitrocellulose membranes for immunoblotting with anti-Panx3
antibody.

GAPDH was used as a control to detect any unexpected biotin

internalization.
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2.3 RESULTS
We have previously shown that the Cx43-positive BICR-M1Rk (rat mammary
tumor) cell line is an excellent reference model for investigating dynamic delivery
events, assembly and turnover mechanisms of Cx43 [96, 109]; therefore, we
designed our experimental approach to compare Panx1 and Panx3 trafficking
dynamics in Cx43-positive BICR-M1Rk cells. We engineered stable cells lines to
ectopically express Panx1 or Panx3. Western blots analysis revealed that wildtype BICR-M1Rk cells are negative for Panx1 and Panx3 (Figure 2.1A) but when
engineered to express pannexins, Panx1 resolved as multiple species ranging
from ~41-48 kDa; whereas, Panx3 was detected as a doublet at ~43kDa (Figure
2.1A). These multiple pannexin species have previously been shown to be the
result of glycosylation [25, 47]. Immunolabeling of both Panx1 and Panx3
revealed that both of these pannexins were capable of trafficking and localizing in
a relatively uniform pattern at the apposing cell surface (Figure 2.1B). In contrast,
detectable Panx2 and Panx2-GFP were mainly localized in the intracellular
compartments of, not only BICR-M1Rk cells, but also in HEK 293T, NRK and rat
keratinocytes (Supplementary Figure 1). Not unexpected, the co-expression of
Panx2 with Panx2-GFP did not alter the distribution pattern of untagged or
tagged Panx2. These studies indicate that Panx2 has a unique distribution when
compared to Panx1 and Panx3 even when expressed in the same reference
cells.
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Figure 2.1 Panx1 and Panx3 are capable of trafficking to the cell surface in
BICR-M1Rk cells
BICR-M1Rk cells were engineered to stably express Panx1 or Panx3.
Immunoblotting with affinity purified antibodies (anti-Panx1 and anti-Panx3)
revealed multiple banding profiles of Panx1 (~41-48 kDa) and Panx3 (~41-43
kDa) (A). β-actin was used as a protein loading control (A). Immunolabeling of
Panx1 and Panx3 (B) identified that both pannexins trafficked and localized to
the cell surface (arrows). Nuclei are stained with Hoechst 33342 (blue). Bars= 10
µm. Representative of three independent experiments.

44

2.3.1 Trafficking of Panx1 and Panx3 is mediated
through Sar1-dependent COPII vesicles
It has been widely documented that Sar1 (secretion associated and Ras related)
GTPase is critical for COPII (coat protein II) assembly and vesicular transport of
newly synthesized proteins from the endoplasmic reticulum (ER) compartment
[121, 122]. Dominant-negative GTP-bound mutant Sar1H79G has previously been
shown to block the ER-Golgi transport of newly synthesized Cx43 in BICR-M1Rk
cells [88]. In order to determine if Panx1 and Panx3 follow the classical ER-Golgi
secretory pathway mediated through a COPII-dependent mechanism, we
engineered BICR-M1Rk cells to co-express Panx1 or Panx3 along with Sar1WT or
Sar1H79G. Co-expression of Panx1 with Sar1WT revealed a typical uniform
distribution of Panx1 at the cell surface (Figure 2.2A, arrows), while Sar1WT was
localized to the paranuclear region in an intact Golgi-like compartment (Figure
2.2A, B). In comparison, expression of Sar1H79G resulted in fragmentation of a
Golgi-like compartment in the paranuclear region (Figure 2.2A, B); and retention
of Panx1 and Panx3 in ER-like patterns with little evidence of cell surface
localization (Figure 2.2A, B arrowheads). In the same culture environments,
BICR-M1Rk cells expressing Panx1 or Panx3 but not Sar1H79G revealed a uniform
cell surface labeling of Panx1 and Panx3 (Figure 2.2A, B inserts, arrows).
Furthermore, as we previously reported [88], the distribution of Cx43 gap junction
plaque-like structures was not evident in the presence of Sar1H79G (not shown).
Since Panx1 and Panx3 resolve as multiple bands (Figure 2.1A and 2C), we
wanted to determine the effect of dominant-negative Sar1 on the different
molecular species.
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Figure 2.2 Trafficking of Panx1 and Panx3 was disrupted in the presence of
a dominant-negative Sar1 mutant
BICR-M1Rk cells expressing Panx1 or Panx3 together with Sar1WT or Sar1H79G
were immunolabeled for Panx1 (A) or Panx3 (B). Both Panx1 and Panx3 were
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capable of trafficking and localizing to the cell surface in the presence of Sar1WT
(A, B filled arrows). Expression of Sar1H79G resulted in Panx1 and Panx3 being
retained in an ER-like compartment (A, B arrowheads); however, when cells
expressed Panx1 or Panx3 without expressing Sar1H79G in the same cellular
environment, both Panx1 and Panx3 trafficked to the plasma membrane (A, B,
insets, arrows). Western blotting of Panx1 and Panx3 in the presence of Sar1H79G
(C), or after long term BFA treatment (19hr; D) revealed an accumulation of the
high mannose species of Panx1 and Panx3, with a noticeable reduction in the
higher molecular weight glycosylation species (C and D). Nuclei are stained with
Hoechst 33342 (blue).
experiments.

Bars= 10 µm. Representative of three independent

47

When compared to Panx1 alone or with Sar1WT, the presence of Sar1H79G
revealed an accumulation of the intermediate species (previously demonstrated
to be a high mannose glycosylation species [47]), with a noticeable reduction in
the most extensively glycosylated species of Panx1 (Figure 2.2C). Similarly, an
accumulation of lower molecular weight species (previously reported to be a high
mannose glycosylation species [59]) of the Panx3 doublet was also revealed in
the presence of Sar1H79G (Figure 2.2C), suggesting that the higher molecular
weight species of Panx1 and Panx3 is the consequence of additional posttranslational processing that occurs upon exiting the ER. Consistently, long term
brefeldin A (BFA) treatment (19hr) (a pharmacological blocker known to inhibit
anterograde transport of proteins between the ER and Golgi apparatus [123]) of
Panx1 and Panx3 expressing BICR-M1Rk cells caused a detectable increase in
the high mannose species of Panx1 and Panx3, with a noticeable reduction in
the higher molecular weight species of both Panx1 and Panx3 (Figure 2.2D).
Collectively, these results suggests that both Panx1 and Panx3 are cotranslationally inserted into the ER and transported in a COPII-dependent
mechanism to the Golgi apparatus, where they are substrates for further
glycosylation and processing.

2.3.2 GFP-tagged Panx1 mimics the distribution profile
of untagged Panx1 and is suitable to investigate the
dynamic distribution of Panx1
In order to assess the dynamic properties of Panx1, we first stably expressed
Panx1-GFP in BICR-M1Rk cells and evaluated its distribution profile with respect
to untagged Panx1. Immunofluorescent labeling revealed that Panx1-GFP
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exhibited a similar cell surface distribution pattern (Figure 2.3A, arrows) as
observed for untagged Panx1 (Figure 2.3F, arrows), with a notable increase in
intracellular fluorescent signal (Figure 2.3A). Clearly, the cell surface pattern for
Panx1-GFP was distinct from that observed for Cx43-GFP when expressed in
the same cell type (Figure 2.3A, insert). To assess the dynamic activity of Panx1
at the cell surface and within intracellular compartments we performed rapid
time-lapse imaging on cells that expressed Panx1-GFP. Panx1-GFP was not
only visualized in a relatively uniform pattern at the cell surface (Figure 2.3A), but
also as mobile bright fluorescent clusters (Figure 2.3B and C). Rapid time-lapse
imaging revealed that these clusters (suggestive of Panx1-GFP aggregates)
were mobile at the plasma membrane and in regions devoid of cell-cell contacts
(Figure 2.3B and C, filled arrows, see Movie 2.1). In addition, Panx1-GFP was
also found in distinct intracellular vesicle-like structures that were highly mobile
(Figure 2.3D, unfilled arrows, Movie 2.1). Surprisingly, and distinct from that
observed for functional Cx43, Panx1-GFP was found in dynamic finger-like
projections indicative of membrane protrusion (Figure 2.3E, arrowheads, Movie
2.1). This localization to membrane protrusion was also frequently evident in cells
expressing untagged Panx1, suggesting that this localization profile is not a
consequence of the GFP tag (Figure 2.3F, arrowheads).
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Figure 2.3 Panx1 was localized to multiple sites, compartments and
microdomains
Immunolabeling of Panx1-GFP with an anti-Panx1 antibody revealed its
localization at the cell surface (A, filled arrows) in a pattern that was distinct from

50

Cx43-GFP (A, insert). Regions of interest from live BICR-M1Rk cells expressing
Panx1-GFP (B, red and blue rectangles) were chosen for live imaging and
imaged at t= 0, 10, 50, 70 and 110 seconds (C and D). Rapid time-lapse imaging
revealed that Panx1-GFP is distributed primarily in a uniform pattern, while
mobile bright fluorescent clusters could be identified at the cell surface (B and C,
filled arrows) and within the cell (D, unfilled arrows). Panx1-GFP was clearly
localized to dynamic plasma membrane protrusions (E, arrowheads), that were
evident in BICR-M1Rk cells expressing untagged Panx1 (F, arrowheads). Nuclei
in A and F are stained with Hoechst 33342 (blue). Bars= 10µm. Representative
of three independent experiments. See Movie 2.1: http://www.jbc.org/
Movie 2.1 Dynamic structures carrying Panx1-GFP are distributed
intracellularly and at the cell surface
Rapid time-lapse imaging was performed on Panx1-GFP expressing BICR-M1Rk
cells to assess the overall localization and distribution pattern of Panx1. Panx1GFP was localized in a relatively uniform manner at the cell surface with some
evidence of cell surface clusters. Intracellular vesicle-like structures carrying
Panx1-GFP were evident as bright clusters. Panx1-GFP was also localized to
membrane protrusions that were constantly being remodeled. The movie
sequence represents 32 frames scanned every 5 seconds, with a total elapsed
time of 160 seconds.

51

2.3.3 Panx1-GFP is highly mobile at all plasma
membrane domains as revealed by FRAP analysis
To analyze the dynamic mobility characteristics of Panx1-GFP, we first assessed
the ability of Panx1-GFP to traffic and localize at three distinct plasma membrane
domains where there was no neighboring cell (Figure 2.4A, red arrow), the
neighboring cell expressed Panx1-GFP (Figure 2.4A, blue arrow), or the
neighboring cell was devoid of Panx1-GFP (Figure 2.4A, purple arrow). Once it
was determined that Panx1-GFP was not differentially distributed to any of these
cell surface domains (Figure 2.4A), regions of Panx1-GFP located at these
distinct domains were selected and subjected to fluorescence recovery after
photobleaching (FRAP) analysis (Figure 2.4B-E). After initial photobleaching,
within 2 seconds there was a rapid movement of fluorescent molecules from the
outer edges into the photobleached area of all bleached cell surface domains
(Figure 2.4B-D, inserts). FRAP curve analysis revealed the mobile fluorescent
fractions to be 45-60% at all micro-domains over a time course of only 60
seconds (Figure 2.4E). Moreover, there was no significant difference in the total
recovered fraction of Panx1-GFP within any of the plasma membrane domains;
an observation that was similar to when we analyzed the percentage recovery of
transiently transfected Panx1-GFP (40-50%) in BICR-M1RK cells stably
expressing untagged Panx1 (Supplementary Figure 2), or B16-BL6 cells,
identified for the first time to express endogenous Panx1 (Supplementary Figure
3A and B).
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Figure 2.4 Panx1-GFP is highly mobile at all plasma membrane locations
Panx1-GFP was localized to three distinct plasma membrane domains of BICR-
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1Rk cells, as depicted by the schematic diagram (A). Fluorescent images of
Panx1-GFP

were

superimposed

with

DIC

images

to

highlight

the

microenvironment surrounding the cell being analyzed (A-D). Selected cell
regions where Panx1-GFP was localized at the three distinct plasma membrane
domains were photobleached and fluorescence recovery back into the
photobleached areas was assessed and normalized over 60s (B, C and D).
Panx1-GFP recovery within the photo-bleached area was not significant different
(P>0.05) amongst all three domains (E). Bars = 10 µm. n = 6-9 per plasma
membrane domain collected from three independent experiments.
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2.3.4 A sub-population of GFP-tagged Panx3 is evident
at the cell surface when expressed alone or coexpressed with Panx3 and reveals dynamic localization
to the membrane protrusions
We have previously reported that Panx3-GFP has a substantial trafficking defect
causing it to be retained within the endoplasmic reticulum of NRK cells [25].
However, when over-expressed in BICR-M1Rk cells, some evidence of Panx3GFP localization to the cell surface was detected (Figure 2.5A, filled arrows),
along with the intracellular ER-like distribution of Panx3-GFP (Figure 2.5A,
unfilled arrows). To further confirm that a sub-population of Panx3-GFP can
traffic and localize to the cell surface, we performed biotinylation assays in live
BICR-M1Rk cells transiently expressing Panx3-GFP. Incubation of Panx3-GFP
expressing cells with biotin followed by pull downs with neutravidin beads
revealed that the ~70 kD Panx3-GFP indeed traffics to the cell surface
(Supplementary Figure 4). GAPDH was used as a negative control to confirm cell
integrity and specificity (Supplementary Figure 4). It was interesting to note that
when Panx3-GFP was co-expressed with Panx3 in BICR-M1Rk cells, there was
an apparent increase in the cell surface population of Panx3-GFP (Figure 2.5B,
filled arrows), with some expected intracellular distribution (Figure 2.5B, unfilled
arrows). This data suggests that Panx3-GFP may interact with Panx3 to facilitate
its traffic to the plasma membrane.
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Figure 2.5 Delivery of Panx3-GFP to the cell surface
Wild-type BICR-M1Rk cells engineered to express Panx3-GFP (A), or both Panx3
and Panx3-GFP (B) were immunolabeled with anti-Panx3 antibody. Panx3-GFP
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was retained mainly in an ER-like pattern (A, B, unfilled arrows) with some
evidence of a cell surface distribution (A, B, filled arrows), while co-expression of
Panx3 appeared to increase the cell surface population of Panx3-GFP (B). Rapid
time-lapse imaging of live BICR-M1Rk cells co-expressing Panx3-GFP and
Panx3 revealed that Panx3-GFP was distributed primarily in a uniform pattern
with notable mobile fluorescent clusters at the cell surface (C, filled arrows), and
within the cell (C, unfilled arrow). Localization of Panx3-GFP to plasma
membrane protrusions (D, arrows) was similar to that found in cells expressing
only Panx3 (E, arrows). Nuclei in A, B and E are stained with Hoechst 33342
(blue). Bars= 10 µm. Representative of three independent experiments.
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To assess the dynamic activity of Panx3-GFP at the cell surface and within
intracellular compartments, we performed rapid time-lapse imaging on cells coexpressing Panx3 and Panx3-GFP. Panx3-GFP was localized at the cell surface
in a relatively uniform pattern and as bright clusters either approaching or at the
cell surface (Figure 2.5C, filled arrows). In addition, Panx3-GFP was also
visualized in distinct vesicle-like structures (Figure 2.5C, unfilled arrows); and
observed in cell surface protrusions (Figure 2.5D, arrows), that were also
occasionally identified in cells expressing only Panx3 (Figure 2.5E, arrows).

2.3.5 Panx3-GFP is highly dynamic at all cell surface
domains
We co-expressed Panx3 with Panx3-GFP and used GFP-tagged Panx3 as a
tracer to assess and quantify the mobile fraction in various plasma membrane
domains where: the neighboring cell surface was devoid of Panx3-GFP (Figure
2.6A), the neighboring cell expressed Panx3-GFP (Figure 2.6B, see Movie 2.2)
or there was no neighboring cell (Figure 2.6C). FRAP analysis of selected
regions expressing Panx3-GFP revealed that within 60s after photobleaching,
there was a rapid re-entry of GFP-tagged Panx3 molecules into the
photobleached area at all micro-domains (Figure 2.6A-C, inserts), and the mobile
fraction was calculated to be ~30-40%. However, no significant difference was
noticed in the total recovered fraction of Panx3-GFP within any of the plasma
membrane domains (Figure 2.6D).

58

Figure 2.6 Panx3-GFP is highly mobile at all plasma membrane domains
Panx3-GFP was localized to three distinct plasma membrane domains of BICRM1Rk cells co-expressing Panx3 (A-C). Selected cell surface regions containing
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Panx3-GFP were photobleached and fluorescence recovery back into the
photobleached areas was assessed and normalized over the time course of 60s.
The percent Panx3-GFP recoverable fraction was not found to be significantly
different amongst all three plasma membrane domains examined (P>0.05) (D).
Bars=10µm. n=12-25 per plasma membrane domain collected from three
independent experiments. See Movie 2.2: http://www.jbc.org/
Movie 2.2 The cell surface population of Panx3-GFP is highly mobile
FRAP and rapid time-lapse imaging was performed at cell-cell interfaces where
both cells co-expressed Panx3-GFP and Panx3. After photobleaching, Panx3GFP rapidly migrated into the photo-bleached area. Intracellular vesicle-like
structures carrying Panx3-GFP were evident as were bright fluorescent clusters
at the cell surface. Panx3-GFP was also observed to be present in actively
remodeling membrane protrusions. The movie represents 31 frames scanned
every 2 seconds, with a total elapsed time of 62 seconds.
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2.3.6 Cell surface population of Panx1-GFP and Panx3
is insensitive to nocodazole treatment
It has been documented that nocodazole disruption of microtubules impairs the
continuous trafficking and regeneration of Cx43-GFP at the cell surface [88]. To
investigate if trafficking and recovery of Panx1-GFP into the photobleached area
is dependent on microtubules, Panx1-GFP expressing BICR-M1Rk cells were
exposed to nocodazole for 90 minutes. Nocodazole treatment resulted in
characteristic morphological changes in the cells from spindle-shaped to more
cuboidal with a notable disruption of the microtubule architecture (Figure 2.7A-C).
However,

the

distribution

of

Panx1-GFP

(Figure

2.7B)

and

Panx3

(Supplementary Figure 2.7.5B) at the cell surface remained relatively unaffected
by the nocodazole treatment. Furthermore, FRAP studies revealed that Panx1GFP migrated into the photobleached area similarly in both untreated and
nocodazole-treated cells (Figure 2.7C, D). Interestingly, the inward progression
of fluorescent recovery from the edges of the photobleached area towards the
centre was not detected until 10 seconds post bleaching (Figure 2.7C, insert).
Furthermore, FRAP analysis of Panx1-GFP in the presence of nocodazole
treatment, revealed no significant difference in the recovered fraction when
compared to the untreated cells (Figure 2.7D). Thus, nocodazole treatment does
not visually affect the cell surface localization of Panx1-GFP, or the recovery into
the photobleached area at the cell surface.
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Figure 2.7 The cell surface population of Panx1-GFP is insensitive to
nocodazole treatment
Untreated (A) or nocodazole-treated (B) Panx1-GFP expressing BICR-M1Rk
were immunolabeled for tubulin. As expected, nocodazole treatment collapsed
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tubulin into paranuclear regions (A, B); however, the distribution profile of Panx1GFP at the cell surface and in the intracellular compartments (A, B) remained
relatively unchanged with collapsed tubulin (B). FRAP analysis in presence of
nocodazole

revealed

that

Panx1-GFP

was

able

to

recover

into

the

photobleached area and the percentage of recoverable fraction was not
significantly different from the untreated cells (C and D). Bars= 10µm. n = 5-10
per plasma membrane domains, data collected over four independent repeats.
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2.3.7 The cell surface stability of Panx1-GFP and
Panx3 is sensitive to cytochalasin B treatment while the
mobility of Panx1-GFP transport vesicles is perturbed in
the absence of intact microfilaments
We next wanted to assess the role of actin microfilaments in stabilizing Panx1
and Panx3 at the cell surface as well as evaluating their cell surface dynamic
properties and transport of Panx1-GFP. Treatment of cytochalasin B (90 min)
caused a re-distribution of F-actin from the cell periphery (Figure 2.8A,
Supplementary

Figure

5A)

to

the

paranuclear

region

(Figure

2.8B,

Supplementary Figure 5A), with a subsequent change in cell morphology. In
cytochalasin B treated cells, Panx1-GFP and Panx3 were mainly localized in
intracellular compartments (Figure 2.8B, Supplementary Figure 5A, arrowheads);
while a small population remained evident at the cell surface (Figure 2.8B,
Supplementary Figure 5A, arrows). These findings suggest that actin may play a
crucial role in the cell surface stability of Panx1-GFP and Panx3. FRAP analysis
of the remaining and detectable cell surface population of Panx1-GFP after
cytochalasin B treatment (see Movie 2.3) revealed that Panx1-GFP was mobile
but the recovery rate was slower and the amount of the recovered fraction was
significant less (~15-20%), when compared to the untreated cells (Figure 2.8C).
Furthermore, rapid time-lapse imaging on the same field of cells visualized
before (see Movie 2.4) and after (see Movie 2.5) cytochalasin B treatment
revealed that Panx1-GFP carrying vesicles were freely able to move and travel in
the untreated cells, however, this movement was greatly perturbed when cells
were treated with cytochalasin B with a ~60% decrease in vesicle
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Figure 2.8 Effect of cytochalasin B on Panx1-GFP
Untreated (A) or cytochalasin B treated (B) Panx1-GFP expressing BICR-M1Rk
cells were labeled with phalloidin for F-actin localization. As expected,
cytochalasin B caused the re-distribution of F-actin from the cell surface (A) to
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the paranuclear region (B). The collapse of F-actin microfilaments coincided with
the intracellular accumulation of Panx1-GFP (B, arrowheads) while, a small
population of Panx1-GFP remained evident at the cell surface (B, arrows). FRAP
analysis in the presence of cytochalasin B treatment revealed that the cell
surface population of Panx1-GFP was significantly impaired from entering the
photobleached area (P<0.05) (C) N=3. Quantification of the total distance
traveled by Panx1-GFP carrying vesicles within the same field of cells analyzed
before and after the cytochalasin B treatment indicated a significant (P< 0.05)
reduction in vesicle mobility in cytochalasin B treated cells (D). Bars= 10µm.
Representative of five independent experiments.
Movie 2.3 Panx1-GFP recovery in the photobleached area is reduced in
response to the disruption of actin microfilaments
Panx1-GFP expressing BICR-M1Rk cells pre-treated with cytochalasin B were
subjected to FRAP and rapid time-lapse imaging at a cell surface where there
was no neighboring cell (top of the frame). Recovery of Panx1-GFP into the
photo-bleached area was minimal, becoming evident at roughly 20 seconds post
photobleaching. The movie represents 61 frames scanned every 1 second, with
a total elapsed time of 60seconds. See online at http://www.jbc.org/
Movies 2.4 and 2.5 Movement of Panx1-GFP carrying vesicles is reduced
in response to the disruption of actin microfilaments
Rapid time-lapse imaging was performed on the same field of BICR-M1Rk cells
expressing Panx1-GFP before (Movie 4) and after cytochalasin B (Movie 5)
treatment. Post 45 minutes of cytochalasin B treatment, we observed an
apparent loss of membrane protrusions as well as a reduction in the movement
of intracellular Panx1-GFP carrying vesicles. The movies represent 39 frames for
untreated cells and 41 frames for cytochalasin B treated cells, scanned every 1.5
seconds. See online at http://www.jbc.org/
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movement over a fixed interval of time (8.8s) (Figure 2.8D). Collectively, these
studies suggest that microfilaments play a multifaceted role in pannexin
stabilization at the cell surface and vesicular transport.

2.3.8 F-actin directly binds Panx1 at the carboxy
terminus
To further examine the possible interaction of Panx1 with actin, lysates of wildtype BICR-M1Rk cells engineered to express Panx1 or Panx1-GFP were
subjected to immunoprecipitation of Panx1 prior to immunoblotting for Panx1 or
β-actin. As expected, multiple glycosylated species of Panx1 (resolved below the
IgG band) and Panx1-GFP were detected in the immunoprecipitates and cell
lysates of Panx1 over-expressing cells but not wild-type BICR-M1Rk cells (Figure
2.9A, top panel). Interestingly, β-actin was found to co-immunoprecipitate with
Panx1 from both Panx1 and Panx1-GFP expressing BICR-M1Rk cells (Figure
2.9A, bottom panel). To further validate the interaction of actin with Panx1, we
conducted co-sedimentation assays where polymerized actin was mixed with
GST fusion protein containing the carboxy terminal tail (C-tail) of Panx1. As
observed by Sypro-stained gel, once polymerized, F-actin typically sediments in
the pellet fraction. In the absence of polymerized actin, GST-Panx1 C-tail was
found in both the soluble and pellet fraction (Figure 2.9B). However, when
combined with F-actin, GST-Panx1 C-tail sediments preferentially in the pellet
fraction (Figure 2.9B). As a control, GST alone did not sediment in the pellet
fraction with or without F-actin (Figure 2.9B). Since the Panx1 C-tail fusion
protein detection at ~43kD was partially masked by actin, we cleaved the C-tail of
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Panx1 from the GST and performed a similar co-sedimentation assay. Further
Panx1 immunoblots revealed the Panx1 C-tail at ~15kD in the pellet fraction
(Figure 2.9C). These results suggest that F-actin binds directly to the carboxyl
terminal of Panx1.
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Figure 2.9 F-actin binds Panx1 at the carboxy terminus
Wild-type (WT), or Panx1 or Panx1-GFP expressing BICR-M1Rk cells were lysed
and subjected to immunoprecipitation (IP) for Panx1 prior to immunoblotting (IB)
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the immunoprecipitates and cell lysates for Panx1 or

β-actin.

β-actin co-

immunoprecipitated with Panx1 and Panx1-GFP (A). Monomeric actin was
polymerized into F-actin, incubated with either GST-fusion protein containing the
carboxy-terminal tail of Panx1 (B) or the carboxy-terminal tail of Panx1 alone (C)
and separated into supernatant or pellet fractions (denoted by S and P,
respectively) prior to immunoblotting for Panx1. Panx1 was found to co-sediment
with F-actin in the pellet fractions (B and C). Parallel gels were stained with
Sypro gel stain and BSA and GST were used as controls in the co-sedimentation
assays. Representative of three independent repeats.
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2.4 DISCUSSION
With the recent discovery of pannexins as a new family of channel or conduit
forming proteins, there has been a growing interest to elucidate their biochemical
properties, life-cycle and cellular roles.

Previous reports have linked Panx1

channels to the release of ATP in neurons [66] and astrocytes [124], and in
cellular response to pathological insults such as initiation of inflammatory action
[76, 112], ischemia-induced death of neurons [78] and in tumor suppression [53].
Our understanding of Panx3 is even more rudimentary. While Panx3 has been
shown to be a cell surface glycoprotein that forms conduits capable of dye
uptake [25, 125], its cellular function remains largely unknown.

It was our

hypothesis that being integral membrane proteins with sequence relationships to
invertebrate innexin gap junction proteins, Panx1 and Panx3 would exhibit similar
characteristics to the well studied Cx43 gap junction protein in terms of the
secretory pathway governing their trafficking, dynamic properties within the
plasma membrane and interplay with the cytoskeletal network.

2.4.1 Trafficking of Panx1 and Panx3 to the cell surface
It has been well established that Cx43 is co-translationally inserted into the ER
and oligomerizes into connexons in the trans-Golgi network before trafficking to
the plasma membrane [13]. In the case of Panx1, treatment with EndoH and
PNGaseF enzymes have revealed that the lower molecular weight species
constitutes the core protein that gets glycosylated to the high mannose form in
the ER before further glycosylation and processing in the Golgi apparatus and
delivery to the cell surface [25, 47].

Although recent studies have extensively
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focused on correlating glycosylation status with the delivery of Panx1 to the cell
surface [47, 81], molecular mechanisms underlying the secretory pathway taken
by Panx1 and Panx3 were largely unknown. To address if the transport of Panx1
and Panx3 from the ER to the Golgi apparatus is mediated through COPII
vesicles, we transiently co-expressed Panx1 or Panx3 with the dominantnegative GTP-bound mutant Sar1H79F. Stabilization of Sar1 in the dominantnegative GTP bound state has been previously shown to efficiently block COPIImediated ER transport of proteins to the cell surface [126]. Our data
demonstrated that Sar1H79F expression severely inhibited the cell surface
localization of Panx1 and Panx3, thus suggesting that COPII vesicular trafficking
of these pannexin family members is required prior to their eventual delivery to
the cell surface. This data also indicates that efficient GTP hydrolysis of Sar1 is
crucial for regulating their transport from the ER compartment, as restriction of
GTP hydrolysis of Sar1H79G to GDP has been previously shown to arrest the
cargo-containing vesicles at the ER exit sites [122]. Consistent with our findings,
we previously showed that Sar1 function was necessary for delivery of Cx43 to
the cell surface [88]. Our data supports the premise that the post-ER pool of
Panx1 and Panx3 is correlated with pannexin processing to the highly complex
glycosylation species; whereas the accumulation of the high mannose
intermediate species of Panx1 and Panx3 is consistent with retention of Panx1
and Panx3 in the ER. Similar Sar1 GTPase dependency was observed for KATP
channels, where expression of dominant-negative mutants: Sar1H79G (mutant
incapable of hydrolysing GTP) and Sar1T39N (mutant restricted in its ability to
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exchange GDP for GTP) prevented proper channel processing and the cell
surface expression of the channel [127].
ER to Golgi transport of Panx1 and Panx3, as well as their state of glycosylation,
was further confirmed by the use of BFA which is known to inactivate Arf1
thereby inhibiting ER to Golgi transport [128]. Consistent with a previous study
[81] we noticed a dramatic increase in the high mannose form of Panx1 in BFAtreated cells. Interestingly, we also observed an accumulation of the high
mannose species of Panx3 in response to BFA treatment, consistent with the
inhibition of both Panx1 and Panx3 being delivered to the Golgi apparatus for
further processing. Vesicular trafficking of Panx1 and Panx3 would also strongly
suggest that, like Cx43, both proteins are integral transmembrane proteins that
get transported from ER membranes in COPII vesicles.

2.4.2 Mobility Dynamics of Panx1 and Panx3
In our study, we used Panx1-GFP and Panx3-GFP as tracer probes to elucidate
the distribution profile and cell surface dynamics of Panx1 and Panx3. The
distribution of Panx1-GFP at the plasma membrane appeared to be uniform with
occasional Panx1 enriched domains consistent with previous findings using the
untagged Panx1 [25]. In contrast, Panx3-GFP alone revealed an increased
intracellular profile, as reported earlier [25], with some clear evidence of its
localization to the cell surface that was confirmed by cell surface biotinylation
assays. Since adequate delivery of Panx3-GFP to the cell surface was required
to investigate its dynamics at the plasma membrane, we co-expressed it with
untagged Panx3 and found an increased cell surface expression of Panx3-GFP.
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It is possible that Panx3 co-oligomerized with Panx3-GFP to facilitate its delivery
to the plasma membrane; if this holds true, it would also suggest that having a
GFP tag at the carboxy terminal tail of Panx3 does not interfere with the
intermixing of Panx3 subunits. A similar mechanism has been proposed for the
cell surface rescue of a trafficking-defective, glycosylation-deficient mutant of
Panx1 when co-expressed with either wild-type Panx1 or tetracysteine tagged
Panx1, further indicating that tagging of pannexins does not impair its ability to
assemble together with its untagged counterpart [81].
In our study, delivery of both Panx1-GFP and Panx3-GFP to the cell surface
appeared to occur at multiple plasma membrane domains via intracellular
vesicle-like structures that formed bright clusters upon apparent fusion with the
plasma membrane. These clusters were found to be quite mobile and displaced
laterally within the cell surface membrane, thus supporting a model of untargeted
delivery of Panx1 and Panx3 to all cell surface micro-domains. In contrast, Cx43GFP typically known to localize in punctate-like structures at the cell surface, has
been documented to have both an arbitrary delivery to all plasma membrane
domains [88, 96] as well as a preferred microtubule-dependent delivery to
adherens junctions that reside in close proximity to the pre-existing gap junctions
[129]. Interestingly, our data supports the premise that Panx1 and Panx3 are
enriched in membrane protrusions at areas that are devoid of contacting cells, a
situation not typically observed for Cx43 unless non-functional Cx43 mutant
studies are performed [96]. Localization of pannexins in the finger-like membrane
protrusions could suggest it may play a role in cell migration, as the process of
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cell motility typically involves actin polymerization, and entails formation of fan
like or pointed projections (lamellipodium and filopodia, respectively) at the
leading edge [130]. Previously, the absence of Panx1 from the leading edge of a
corneal epithelium wound in P2X7-/- mice was correlated with delayed corneal reepithelialization and compromised wound healing [131]. Other channel forming
proteins such as aquaporin-1 has been implicated in increased cell migration by
localizing to the lamellipodia [132]; whereas, migration of lymphocytes [133] and
embryonic nerve cells [134] have been correlated with voltage-dependent K+
channels, thus supporting the role of channel forming proteins in regulating cell
motility.
Our FRAP assessments of Panx1 and Panx3 mobility identified that, similar to
Cx43 [96], lateral movement of Panx1-GFP and Panx3-GFP occurred from the
outer edge to the centre of the photo-bleached areas. It is notable that while the
recovery of fluorescence into the photobleached area is likely the result of lateral
movement of pannexins due to the time course being examined, there is also
likely a contribution from newly delivery fluorescent protein tagged pannexins to
the cell surface. The relative rate of Panx1-GFP and Panx3-GFP recovery into
the photobleached area was quite comparable in any of the examined plasma
membrane micro domains, thus suggesting that the assembly state of these
pannexin family members remains relatively unchanged with respect to its
subcellular location within the plasma membrane. In our study, Panx1-GFP (and
to a slightly lesser extent Panx3-GFP) exhibited over twice the mobility of Cx43GFP, which are typically arranged in gap junction-like clusters [96]. Slow
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recovery of Cx43-GFP was also reported in HeLa cells [135]. Given the relatively
uniform cell surface distribution of Panx1 and Panx3 that appears to be
untargeted to specific micro-domains, we speculate that these pannexins are not
likely packaged into dense crystalline-like structures as reported for Cx43 [39].
Thus, the distribution and mobility of these pannexins are more in line with other
channels and receptors such as Na+ channels [136], and acetylcholine receptors
[137].
The percent of fluorescence recovery after photobleaching for both Panx1-GFP
and Panx3-GFP (representing the mobile fraction) reached a plateau between
40-60% with the remaining component representing the immobile fraction.
Typically the size of the immobile fraction is dependent on the nature of the
protein and the membrane microenvironment being assessed. For instance, the
immobile fraction of Na+ channels ranges from ~10% in the cell body to ~40% in
the neurite terminals [136]. Likewise, the mobile fraction of glycine receptors
ranges from ~50% in the neuronal cell body to ~70% in the processes [138]. In
addition, the viscosity of the membrane microdomain [139], tethering of proteins
with scaffolds/binding partners or interaction with cytoskeleton can all contribute
to the size of the immobile fraction [140].

2.4.3 Cytoskeletal dependency of Pannexin trafficking
and mobility
In order to assess the role of the cytoskeleton in pannexin trafficking and cell
surface mobility dynamics, we used nocodazole and cytochalasin B to disrupt
microtubules and microfilaments, respectively. Nocodazole-induced disruption of
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microtubules did not significantly alter the cell surface distribution of either Panx3
or Panx1-GFP, which may not be totally unexpected given the predicted long
half-life of Panx1 [25, 47]. This finding is quite distinct from Cx43, where
enhanced growth of gap junctions [89], and Cx43 molecular movement into the
photobleached gap junctions was minimal in nocodazole-treated cells [88]
suggesting that Cx43 is much more dependent on microtubules than Panx1. In
contrast, disruption of microfilaments revealed concomitant accumulation of
paranuclear Panx1-GFP and Panx3 with collapsed actin microfilaments, while
only a subpopulation of Panx1-GFP or Panx3 remained at the cell surface. The
longer turnover dynamics of pannexins, and the rapid intracellular accumulation
upon short term cytochalasin B treatment support the premise that actin provides
stability to the cell surface population of Panx3 and Panx1. On the other hand,
Cx43 gap junctions have been documented to remain considerably more
independent to the assembly state of microfilaments [141]. Mobility assessment
of the remaining cytochalasin B-insensitive subpopulation of Panx1-GFP at the
cell surface revealed a rather smaller mobile fraction of ~35% in the absence of
intact microfilaments. This surprising finding was somewhat distinct from Na, KATPase and reggie-1/flotillin-2 where the disruption of microfilaments caused an
increase in the mobile fraction [142, 143]. The smaller mobile fraction of Panx1GFP noticed in our study may be explained by the fact that transport vesicles
carrying Panx1-GFP either to or from the plasma membrane were less mobile
and this decrease may mechanistically account for the reduced fluorescent
recovery into the photobleached area.

The relative speeds of Panx1-GFP
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carrying vesicles in untreated cells (~0.2 µm/sec) and cytochalasin B treated
cells (~0.07 µm/sec) were also quite different. Although credited to trafficking on
microtubules tracks, vesicles containing Cx43-GFP showed comparable average
speeds of ~0.5 µm/sec in untreated HeLa cells [95].

2.4.4 Interaction of Panx1 with actin
Given the finding that actin microfilaments regulated the distribution and cell
surface mobility of Panx1, we speculated a direct interaction between Panx1 and
actin may exist. Since we were best equipped to address this question for Panx1
we first demonstrated that actin does in fact co-immunoprecipitate with Panx1.
To further assess: 1) if Panx1 binds to monomeric or filamentous actin, 2) if
Panx1 interaction to actin is direct, and 3) which domain of Panx1 might be
responsible for interaction, we conducted co-sedimentation assay with a GSTPanx1 C-tail fusion protein. Here we show that Panx1 sediments preferentially in
the F-actin fraction, the interaction appears to be direct and it is the carboxy
terminal tail of Panx1 that seems responsible for interacting with actin.
Comparatively, actin binding to Cx43 is thought to be facilitated via its interaction
with zonula occludens-1 which is a known Cx43 binding partner [144]. Future
studies will be needed to elucidate the Panx1 motif responsible for actin binding
at the C-terminus, and whether actin also binds to Panx3.
In summary, trafficking and assembly of pannexins is a precisely regulated
process. Our study is the first to report that Panx1 and Panx3 transport is
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dependent on Sar1-mediated COPII vesicles, cell surface Panx1 and Panx3
have dynamic mobility properties, and Panx1 directly interacts with F-actin.
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2.7 SUPPLEMENTARY FIGURES
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Supplementary Figure 2.7.1 Distribution profile of mouse Panx2
BICR-M1Rk, HEK-293T, NRK and REK cells were transiently transfected to
express Panx2 and Panx2-GFP alone or together. Panx2 expressing cells were
immunolabeled for Panx2. In all the cell types, both Panx2 and Panx2-GFP were
primarily localized to intracellular compartments. Bars = 10 µm.
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Supplementary Figure 2.7.2 Characterization of the cell surface dynamics
of Panx1-GFP when expressed in Panx1-expressing BICR-M1RK cells
Panx1 over-expressing BICR-M1Rk cells engineered to co-express Panx1-GFP
were immunoblotted (A) and immunolabeled (B) with anti-Panx1 antibody. Like
untagged Panx1, Panx1-GFP also resolved in a multiple banding profile, where
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β-actin was used as a protein loading control (A).

Immunolabeling of

Panx1+Panx1-GFP cells identified the cell surface and intracellular distribution of
GFP-tagged (B-arrowheads) and untagged (B-arrows) Panx1. Nuclei were
stained with Hoechst 33342 (blue).
membrane

domains

expressing

Bar = 10 µm. Three distinct plasma

Panx1-GFP

were

photobleached

and

fluorescence recovery revealed no significant difference amongst them (C). n =
8-10 per plasma membrane domain collected from three independent
experiments.
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Supplementary Figure 2.7.3 Characterization of the cell surface dynamics
of Panx1-GFP when expressed in Panx1-positive BL6 cells
BL6 cells expressing endogenous Panx1 were transiently transfected with
Panx1-GFP and immunoblotted with anti-Panx1 antibodies (A). β-actin was used
as a protein loading control (A). Exogenously expressed Panx1-GFP (B,
arrowheads) and endogenously expressed Panx1 (B, arrows) exhibited a uniform
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cell surface distribution. Nuclei were stained with Hoechst 33342 (blue). Bar = 10
µm. Photobleaching of Panx1-GFP at three plasma membrane domains revealed
no significant difference in the percentage of recovery (C). n = 9-12 per plasma
membrane domain collected from three independent experiments.
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Supplementary Figure 2.7.4 Panx3-GFP is capable of trafficking to the cell
surface
Cell surface biotinylation of BICR-M1Rk cells transiently expressing Panx3-GFP
indicated that Panx3-GFP can reach the cell surface. Cell lysates of Panx3-GFP
with (+) or without (-) biotin were precipitated with neutravidin beads and
immunoblotted for Panx3. GAPDH was used as a control to assess if biotin had
entered the cell during the labeling procedure.
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Supplementary Figure 2.7.5 The cell surface distribution of Panx3 is
partially sensitive to cytochalasin B and insensitive to nocodazole
treatment
BICR-M1Rk cells transiently expressing Panx3 were treated with cytochalasin B
(A) or nocodazole (B) and co-immunolabeled for Panx3 and tubulin or labeled for
Panx3 together with phalloidin.

In cytochalasin B treated cells, Panx3 was
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mainly localized to intracellular compartments (A, arrowheads), with some
evidence of a cell surface pool (A, arrows); whereas nocodazole treatment
caused no obvious difference in the cell surface distribution of Panx3 (B) Bar =
10 µm.
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CHAPTER 3: The Carboxyl Terminal Tail of Panx1
Regulates Trafficking and Homomeric Interaction

3.0 OVERVIEW

This study was designed to characterize the role of the C-terminal domain of
Panx1 in trafficking and oligomerization, by truncating the polypeptide at residue
307 and comparing its properties to full length Panx1.

_______________________

This chapter is currently in the process of being submitted for publication
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3.1 INTRODUCTION
Pannexins were originally discovered due to their shared sequence homology
with the invertebrate gap junction proteins, innexins [1]. The pannexin family is
comprised of three members: Panx1, Panx2 and Panx3 [1]. Although the scope
of physiological significance of pannexin family members is only beginning to
emerge, it is well established that Panx1 holds importance in: forming conduits
for ATP release [57, 145, 146], propagation of Ca2+ waves [60], and triggering
neuronal and immunological inflammasome [49, 77, 147]. Additionally, activation
of Panx1 channels has been implicated in ischemic cell death [78], and seizurelike activities [66]. In order to fulfill a wide spectrum of biological functions, a
precise regulation of pannexin assembly and trafficking is required.
In general, glycosylation of integral membrane channel proteins can have
important implications on proper folding and subunit assembly, cell surface
expression, and function [148-150]. We and others have shown that Panx1 is Nlinked glycosylated [25, 47] and exists as core (Gly0), high mannose (Gly1) and
complex (Gly2) species [59].

The significance of Panx1 glycosylation on

trafficking was first explored using site-directed mutagenesis of putative N-linked
glycosylation sites [47]. While the Panx1N204Q mutant was fully glycosylated and
expressed all the three forms: Gly0, Gly1 and Gly2, the Panx1N254Q mutant was
not glycosylated and was expressed only as a Gly0 species [25, 47]. Moreover,
the Panx1N254Q mutant displayed trafficking defects suggesting that glycosylation
played a role in proper trafficking of Panx1 to the cell surface.
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Cell surface Panx1 exists in the form of hexamer channels, termed pannexons
[47]. In MDCK cells, Panx1 has been shown to rescue the delivery of the
Panx1N254Q mutant to the cell surface suggesting that they co-oligomerize [81].
Thus, the lack of glycosylation does not perturb the ability of Panx1N254Q subunits
to fold properly and intermix with Panx1. Interestingly, despite the glycosylation
deficiency and the low levels of the Panx1N254Q mutant at the cell surface, the
mutant is still capable of forming functional single membrane channels that can
take up dye [25]. A glycosylation deficient mutant of zebrafish Panx1 (zfPanx1N246K), on the other hand, traffics to the cell surface, but displays impaired
uptake of ethidium bromide compared to WT zfPanx1 [151].
The function of Panx1 channels has also been investigated by engineering
specific point mutations in the polypeptide sequence and expressing these
mutants in reference cell models. First, substitution of lysinealanine at residues
248 and 265 in the second extracellular loop resulted in a loss of Panx1 channel
function. Mutation of arginine at position 75 (in the first extracellular loop) to
alanine, lysine, glutamine, or cysteine was further used to assess the inhibitory
effects of ATP analogues on Panx1 channel currents [63]. Based on the single
mutation analysis of these mutants, R75 was identified as a key ATP binding site
for regulation of Panx1 channel activity [63]. When expressed in Xenopus
oocytes, the C346S mutant formed constitutively leaky channels thereby causing
cell death; whereas C136S or C436S mutants did not significantly alter Panx1
channel properties [152].

Although the C346S mutant was only partially

glycosylated to the Gly1 form, as opposed to the full glycosylation states
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achieved by the C136S and C426S mutants, all three mutants trafficked and
localized to the cell surface [152]. Thus, these results suggest that partial
glycosylation of Panx1 to the high mannose species (Gly1) is sufficient to drive a
subpopulation to the cell surface, a notion further supported by our recent work
demonstrating cell surface biotinylation of the Gly1 species of Panx1N254Q [59].
Clearly, engineering of mutations along several domains of Panx1 provide
insights into Panx1 assembly, trafficking and channel function. While several
studies have investigated at the effect of single amino acid substitutions within
specific Panx1 motifs, mutants where entire Panx1 domains have been deleted
have not be studied. We were particularly interested in the large 127 amino acid
long C-terminal domain as this cytoplasmic domain is a prime candidate exposed
for interacting with other regulatory proteins. In fact, we have previously shown
that the Panx1 C-tail acts as a substrate for binding actin, which provides a
multifaceted role in vesicular transport, cell surface mobility, and stability of
Panx1 [153]. In the present study we expand our understanding of the role of the
Panx1 C-terminus by investigating the trafficking and oligomeric potential of Cterminal truncated Panx1.
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3.2 EXPERIMENTAL PROCEDURES
3.2.1 Cell culture and reagents
BICR-M1Rk cells and human embryonic kidney (HEK)-293T, cells were cultured
in high glucose DMEM (Invitrogen, Burlington, ON, Canada), supplemented with
10% fetal bovine serum, 100 units/ml penicillin, 100 µg/ml streptomycin, and 2
mM L-glutamine (all from Invitrogen, Burlington, ON, Canada).

3.2.2 Expression constructs and transfection
To truncate Panx1 carboxy tail at amino acid position 307, primers were
designed with flanking sites for HindIII digestion- using the forward primer: 5’GATAAGCTTACCATGGCCATCGCCCAC, and NotI digestion for reverse primer:
5’- TCAAGCGGCCGCACCACTTTGAGAATG. PCR products were digested with
HindIII and NotI restriction enzymes, and inserted into the pcDNA3-mRFP vector
(Addgene Plasmid Repository). Truncated Panx1 and RFP (denoted as
Panx1T307-RFP) were separated by a five-amino acid polylinker encoded by the
nucleotide sequence (GGACCGGTCGCCACC). The resulting construct was
validated by sequencing.
To create the Panx1-RFP construct, full length Panx1 (encoding 426 amino
acids) was excised from a previously engineered pEGFP-N1 vector [25] using
HindIII and BamHI restriction enzymes. Panx1 was fused with RFP in frame to
the carboxyl terminus in the pcDNA3-mRFP vector by a thirty one amino acid
polylinker

encoding

by

the

nucleotide

sequence:
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(CTGTCGACGGTACCGCGGGCCCGGGATCCACTAGTAACGGCCGCCAGTG
TGCTGGAATTCTGCAGATATCCATCACACTGGCGGCCGCTCGAG).
For transfection of Panx1T307-RFP and Panx1-RFP, cells were grown overnight to
50-70% confluency in 35 mm dishes and transfected in Opti-MEM1 (Invitrogen)
media containing 2 μL of Lipofectamine 2000 (Invitrogen) and 5 µg of plasmid
DNA. For co-expression studies, HEK-293T cells were plated in 100 mm dishes
and 7-9 µg of Panx1 was co-transfected with 10-15 µg of either Panx1T307-RFP
or Panx1-RFP in Opti-MEM1 media containing 15 μL of Lipofectamine2000.
Opti-MEM1 media was replaced with complete culture media 4 hours after
transfection at 37˚C.

3.2.3 Immunocytochemistry
Cells were immunolabeled as previously described [153]. Briefly, cells grown on
a glass coverslips were fixed using ice-cold 80% methanol and 20% acetone for
20 minutes at 4˚C and blocked in 2% blocking solution (Bovine Serum Albumin (BSA; Sigma)) for 30 minutes. Cells were incubated for 1 hour at room
temperature with affinity-purified polyclonal Panx1 antibody at a concentration of
2 μg/mL, a 100 fold dilution of monoclonal anti-GM130 antibody (BD
Transduction Laboratories), a 500 dilution of monoclonal anti-PDI antibody
(Stressgen) or a 200 fold dilution of polyclonal anti-RFP antibody (Abcam). Cells
were incubated with goat anti-rabbit or goat anti-mouse Alexa Fluor488 (1:500,
Invitrogen) for 45 minutes at room temperature. Cells were rinsed with PBS and
nuclei were stained with Hoechst 33342 and mounted. Immunolabeled cells were

95

imaged using a 63x oil objective lens mounted on a Zeiss LSM 510 META (Zeiss,
Toronto, ON) system.

3.2.4 Co-Immunoprecipitation and immunoblotting
Protein lysates were collected from cells expressing Panx1T307-RFP and Panx1RFP with or without Panx1 using a lysis buffer as previously described [153].
Protein concentrations were measured using a BCA protein determination kit
(Pierce). The co-immunoprecipitation assay was performed mainly as previously
described [154]; briefly, 1 mg of each protein lysate was incubated with 10 μg/ml
of anti-Panx1 CT-395 antibody and rocked overnight at 4°C. The following day,
30 μl (50% slurry) of protein A-Sepharose beads were added to the lysates and
incubated for an additional 2 hours at 4°C. Thereafter, beads were collected by
centrifugation at 4500 rpm for 2 minutes, washed three times to remove any
nonspecific binding, and boiled for 5 minutes in 2x Laemmli buffer prior to
resolving on 8-10% SDS-PAGE gels.
For cellular lysates control, a total of 30-40 µg of protein was used, and gels were
transferred to a nitrocellulose membrane using the iBlot Dry Blotting system
(Invitrogen). Nitrocellulose membranes were blocked in 3% BSA or 5% blotto
milk (Santa Cruz Biotechonologies), and probed overnight with polyclonal affinity
purified anti-Panx1 (0.2 µg/mL) or polyclonal anti-RFP (1:2,000) antibodies at
4˚C. Monoclonal anti-GAPDH antibody (1:10,000, Millipore) was used to assess
protein loading. Since both the RFP and Panx1 antibodies were raised in rabbits,
detection of co-immunoprecipitates was achieved using the Clean-Blot IP
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Detection Reagent (horse radish peroxidase; Pierce Chemical) as a secondary
antibody at 1:4,000 dilution for 45 minutes, in order to minimize the appearance
of the IgG bands.

Blots were incubated in reagents from SuperSignal West

Femto chemiluminescent kit (Pierce Chemical) prior to scanning with the BioRad
system. For cell lysates, detection of primary antibody binding was performed
using mouse IgG IR dye 800 at 1:10,000 (Rockland Immunochemicals) or rabbit
IgGAlexa 680 at 1:10,000 (Invitrogen) and scanning with the Odyssey infrared
imaging system (Licor).

3.2.5 Deglycosylation assays
Enzymatic digestion of glycan chains using peptide N-glycosidase (PNGase) F
and endo-β-N-acetylglucosaminidase (Endo) H were performed as previously
described [59]. Briefly, 35 μg of HEK-293T cell lysates containing either
Panx1T307-RFP or Panx1-RFP were incubated in the presence or absence of 10U
of N-glycosidase F and incubated for 1 hour at 37°C prior to immunoblotting
using the RFP antibody. Similarly, for Endo H treatment, 35 μg of protein was
incubated with or without 5000U of the enzyme for 1 hour at 37°C and samples
were resolved on a 8% SDS PAGE before transferring to nitrocellulose
membranes and probing with an anti-RFP antibody.

3.2.6 Cell surface biotinylation
HEK-293T cells ectopically expressing either Panx1T307-RFP or Panx1-RFP were
subjected to biotinylation 48 hours following transfection. To prevent any
potential internalization of cell surface proteins, all reagents and cell cultures
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were maintained on ice. Cell culture dishes were first rinsed three times with cold
PBS to remove media and incubated thereafter either in PBS alone or in PBS
containing 1 mg/ml of EZ-link Sulfo NHS-LC biotin (Pierce Chemical) for 20
minutes at 4°C.To quench any excess biotin, cell culture dishes were first rinsed
and then incubated in PBS containing 100 mM glycine for an additional 15
minutes at 4°C. Proteins were then extracted from both unlabeled and biotin
labeled dishes using the SDS lysis buffer (1% Triton X-100 and 0.1% SDS in
PBS), and quantified using a BCA protein determination kit (Pierce). 1 mg of cell
lysates from biotin labeled and unlabeled samples were incubated with 50 μl of
NeutrAvidin-agarose beads (Pierce Chemical) overnight at 4°C. The following
day, beads were washed with IP lysis buffer (150 mM NaCl, 10 mM Tris-HCl, pH
7.4, 1 mM EDTA, 0.5% NP-40, and 1% Triton X-100) containing 1 mM NaF and 1
mM Na3VO4, and suspended in 2x Laemmli buffer before boiling for 5 minutes
and resolving on the SDS-PAGE. Total protein containing 30-40 μg of lysate was
simultaneously resolved on the gel, transferred to nitrocellulose and probed for
RFP and Panx1 expression.

3.2.7 Pharmacological inhibitors
HEK-293T cells expressing Panx1T307-RFP and Panx1 together or individually
were exposed to 10 µM of lactacystin (Sigma) and 200 µM of chloroquine
(Sigma) for 20 hours prior to protein extraction. Total protein lysates of treated
and untreated cells were then subjected to immunoblotting for RFP and Panx1.
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3.3 RESULTS
In order to characterize the biological significance of the Panx1 C-tail, we
truncated Panx1 at residue 307 that is approximately 10 amino acids
downstream of where the fourth transmembrane domain is predicted to exit the
plasma membrane. To facilitate detection of the Panx1 truncated mutant, the
mutant was tagged with red fluorescent protein (RFP). To control for any possible
adverse effect of the RFP tag, we also tagged full length Panx1 with RFP to be
used in comparative studies.

3.3.1 RFP tagging does not modify the distribution
profile of Panx1
RFP is a fluorescent protein derived from Discosoma coral that is spectrally
distinct from the green fluorescent protein (GFP), originally cloned from
Aequorea jellyfish [155]. In order to validate that the RFP tag does not modify
the trafficking of Panx1, we compared it to the GFP-tagged version that
previously showed similar cell surface delivery and localization patterns to
untagged Panx1. Transfection of Panx1-RFP in BICR-M1Rk cells stably
expressing Panx1-GFP revealed relatively uniform co-localization at the cell
surface and overlap in vesicle-like compartments distributed intracellularly
(Figure 3.1A, arrowheads). Interestingly, similar to Panx1-GFP, RFP-tagged
Panx1 was also found in plasma membrane protrusions (Figure 3.1B, arrows).
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Figure 3.1 Panx1-RFP co-localize with Panx1-GFP
Over-expression of Panx1-RFP (red) in BICR-M1Rk cells stably expressing
Panx1-GFP (green) resulted in their co-localization (yellow) in a relatively uniform
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pattern at the cell surface and in vesicle-like structures (A, arrowheads). Panx1RFP also co-localized (yellow) with Panx1-GFP at the plasma membrane
protrusions (B, arrows). Nuclei were counterstained with Hoechst. Bar = 10 µm.
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This suggests that like GFP, RFP tagging of the Panx1 carboxyl terminal tail also
displays distribution characteristics similar to the untagged counterpart and
therefore could be employed as a control to study the biological properties of
Panx1T307-RFP.

3.3.2 The C-tail of Panx1 is important for trafficking to
the plasma membrane
Both Panx1T307-RFP and Panx1-RFP were over-expressed in either BICR-M1Rk
or HEK-293T cells, as these cell lines are devoid of endogenous Panx1 [59, 153].
The high transfection efficiency of HEK-293T cells was deemed ideal for
immunoblotting experiments; however, given their small spindle morphology,
large nuclei and low cytoplasmic volume [59], they were not as suitable for
immunolocalization studies as the larger BICR-M1Rk cells.
When Panx1T307-RFP was expressed in BICR-M1Rk cells the mutant was found
to primarily reside in intracellular compartments (Figure 3.2A). In contrast, full
length Panx1-RFP was capable of trafficking and localizing to the cell surface in
a relatively uniform manner (Figure 3.2B). As expected, the Panx1 CT-395 (from
here on denoted as the anti-Panx1) antibody detected the full length Panx1-RFP
but was unable to detect Panx1T307-RFP due to the deletion of the antigenic
epitope used to generate the antibody (Figure 3.2A and B). In comparison, the
RFP antibody detected both Panx1T307-RFP and Panx1-RFP (Figure 3.2C and
D). Interestingly, the subcellular distribution profile of both Panx1T307-RFP and
Panx1-RFP was consistent between BICR-M1Rk and HEK-293T cells (Figure
3.2E and F), eliminating any potential cell type differences.
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Figure 3.2 The C-tail of Panx1 is critical for trafficking to the cell surface
Panx1T307-RFP was localized to the intracellular compartments (A, red) while
Panx1-RFP was found at the cell surface (B, red) in BICR-M1Rk cells.
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Immunolabeling with Panx1 detected Panx1-RFP and not Panx1T307-RFP (A and
B, green). As expected, the anti-RFP antibody localized both Panx1-RFP and
Panx1T307-RFP (C and D, green). The subcellular distribution of full length and Ctail truncated Panx1 remained consistent in HEK-293T cells (E and F, red).
Nuclei were counterstained with Hoechst. Bar=10µm.
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Collectively, these findings suggest that the C-terminal of Panx1 is critical for
delivery and retention of Panx1 at the cell surface.

3.3.3 Panx1T307-RFP is primarily retained within the ER
compartment and glycosylated to a high mannose form
In order to identify the subcellular localization of Panx1T307-RFP, cells were
immunolabled for ER (PDI and calnexin) and Golgi (GM130) resident proteins.
Although the distribution patterns of both Panx1T307-RFP and PDI (an ER lumen
protein) partially overlap, their localization patterns were not identical (Figure
3.3A). In contrast, the ER integral membrane protein marker, calnexin, revealed
strong co-localization with Panx1T307-RFP, particularly around the perinuclear
region (Figure 3.3B). Not surprisingly, Panx1-RFP at the cell surface did not
localize with either PDI or calnexin (Figure 3.3A and B). Additionally, labeling with
the cis-Golgi matrix protein, GM130, revealed a distinct distribution profile from
both Panx1T307-RFP and Panx1-RFP (Figure 3.3C). Thus, in the absence of the
C-tail it appears that Panx1 is largely retained in the ER compartment. As a
glycoprotein, it is well documented that Panx1 exhibits multiple banding patterns
reflecting the core unglycosylated protein: Gly0; a high mannose glycosylated
species associated within the ER: Gly1; and the extensively glycosylated species
that is modified in the Golgi apparatus prior to cell surface delivery: Gly2 [25, 47,
59]. To address if Panx1T307-RFP also resolves as multiple species, lysates of
HEK-293T wild-type cells, cells over-expressing full length Panx1 fusion proteins,
and the C-tail truncated protein were subjected to immunoblotting using antiRFP and Panx1 antibodies.
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Figure 3.3 Characterization of the subcellular distribution of Panx1T307-RFP
BICR-M1Rk cells ectopically expressing Panx1T307-RFP (red) or Panx1-RFP (red)
were immunolabeled with antibodies against PDI, calnexin and GM130.
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Panx1T307-RFP expressing cells revealed an intracellular pattern that exhibited
partial colocalization with resident proteins of the endoplasmic reticulum. The
bulk of Panx1-RFP trafficked to the cell surface with no obvious co-localization
with PDI (A, merge) or calnexin (B, merge). GM130 (green) was mainly localized
around the perinuclear region.
Bar=10µm.

Nuclei were counterstained with Hoechst.
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Owing to the fusion of RFP (~27-30kD), C-tail truncated Panx1 was detected as
a doublet at a molecular weight of ~50kD, whereas full length Panx1 resolved as
multiple bands at ~75-80kD (Figure 3.4A). Consistent with our immunolabeling
data, the Panx1 CT-395 antibody did not detect Panx1T307-RFP, but identified full
length GFP and RFP -tagged Panx1 (~75-80KD), as well as occasionally some
bands near 50kD, which are likely proteolytic products (Figure 3.4B). As
expected, WT cells did not express any Panx1, however, some non-specific
bands were observed above 50 kDa when probed with the RFP antibody (Figure
3.4A).
In order to determine whether the banding pattern of Panx1T307-RFP was a result
of glycosylation, we enzymatically digested the cell lysates using N-glycosidase F
prior to immunoblotting. Within an hour, N glycosidase F treatment of Panx1RFP removed glycan chains associated with the Gly1 and Gly2 species and
shifted the banding pattern to the level of Gly0 (Figure 3.4C). Similarly, the upper
band of Panx1T307-RFP, likely the Gly1 species, also shifted to the lower band
(Gly0) upon N-glycosidase F digestion (Figure 3.4D). To further assess the
extent of glycosylation, both Panx1T307-RFP and Panx1-RFP were subject to
Endo H digestion, which selectively cleaves the high mannose form of a
glycoprotein. Consistent with previously reported digestion of mouse [47, 59]
and rat untagged Panx1 [47], Endo H treatment of Panx1-RFP revealed a shift in
only the intermediate Gly1 band without reducing the Gly2 species (Figure 3.4E).
Interestingly, the upper band of Panx1T307-RFP was also sensitive to the Endo H
treatment (Figure 3.4F).
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Figure 3.4 Panx1T307-RFP exhibits glycosylation states distinct from Panx1RFP
Protein lysates of HEK-293T WT cells and cells over-expressing Panx1-GFP,
Panx1-RFP and Panx1T307-RFP were immunoblotted for RFP tagged Panx1 (A
and B). Panx1-RFP (A and B) resolved similar to Panx1-GFP (B) in a multiple
banding profile, whereas Panx1T307-RFP was detected primarily as a doublet
~50kD (A). Digestion of Panx1-RFP and Panx1T307-RFP with N-glycosidase F (C
and D) and Endo H (E and F) revealed that while Panx1-RFP can exist as a core
(Gly0), high mannose (Gly1) and complex glycoprotein species (Gly2),
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Panx1T307-RFP primarily consists of core (Gly0) and
species. GAPDH was used as a protein loading control.

high mannose (Gly1)
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Taken together, these results suggest that in the absence of the C-tail,
glycosylation of Panx1 is limited to a high mannose form.

3.3.4 Panx1 is incapable of rescuing Panx1T307-RFP to
the plasma membrane
Panx1 is reported to presumably oligomerize with the glycosylation-deficient
mutant, Panx1N254Q, to rescue its predominant intracellular distribution to the cell
surface [81]. To examine whether the C-tail of Panx1 regulates homomeric
interactions, we transiently co-expressed Panx1 with Panx1T307-RFP. When
Panx1 is ectopically expressed alone or in conjunction with Panx1-RFP, a
relatively uniform cell surface distribution is revealed (Figure 3.5A and B). In
contrast, the intracellular retained Panx1T307-RFP was not rescued to the cell
surface when co-expressed with Panx1; instead, a sub-population of Panx1 was
detected intracellularly in the perinuclear region (Figure 3.5C). Thus, suggesting
that intermixing of Panx1 with the C-tail mutant does not result in rescue of the
mutant to the cell surface.

3.3.5 C-Tail of Panx1 is involved in glycosylationdependent homomeric interactions
To further examine the potential role of the Panx1 C-tail in Panx1
oligomerization, lysates of HEK-293T cells, cell over-expressing Panx1 alone or
in combination with either Panx1-RFP or Panx1T307-RFP were subjected to
immunoprecipitation for Panx1.
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Figure 3.5 Panx1 expression did not relocalize Panx1T307 to the cell surface
HEK-293T cells transfected with Panx1 alone (A), or with Panx1-RFP (B, red)
and Panx1T307-RFP (C, red) were immunolabeled for Panx1 (green). When
expressed alone (A) or with Panx1-RFP (B), Panx1 reached the cell surface and
also colocalized with Panx1-RFP (B, merge). The intracellular localization pattern
of Panx1T307-RFP (red) was evident in the presence of Panx1 (green) (C). Nuclei
were counterstained with Hoechst. Bar=10µm.
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When immunoblotted with either RFP or Panx1 antibodies, immunoprecipitates
of Panx1 co-expressed with Panx1-RFP revealed both the high mannose (Gly1)
and complex glycosylated species (Gly2), with much lower detection of the core
(Gly0) species (Figure 3.6A and B). In contrast, only trace amounts of the Gly1
species of Panx1T307-RFP was found to co-immunoprecipitate with Panx1 (Figure
3.6A). Conversely, immunoblotting with the anti-Panx1 antibody revealed the
Gly1 and Gly0 species with little evidence of the Panx1 Gly2 species when coexpressed with Panx1T307-RFP (Figure 3.6B). Interestingly, total cell lysates also
revealed little Gly2 species of Panx1 in the presence of Panx1T307-RFP (Figure
3.6B). Collectively, these findings suggest that all three species of Panx1 can
readily interact with Panx1-RFP.

In contrast, when the C-tail of Panx1 is

truncated, only a weak interaction exists with Panx1, with a preference for the
core and high mannose species.

3.3.6 Panx1T307-RFP has a dominant-negative effect on
the maturation of Panx1 to the Gly2 Species
To determine the effect of Panx1T307-RFP mutant on the maturation of Panx1 to
the Gly2 species and delivery to the cell surface we conducted a cell surface
biotinylation assay on live HEK-293T cells expressing Panx1T307-RFP, and
Panx1-RFP alone or in combination with Panx1.

As depicted by Panx1

immunoblotting of NeutrAvidin pulled down fractions and cell lysates, all species
of Panx1-RFP were capable of trafficking to the cell surface, with a preference for
the Gly2 species when probed with anti-RFP antibody (Figure 3.7A).
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Figure 3.6 Truncation of the Panx1 C-tail limits the interaction with the full
length Panx1
Immunoprecipitation of Panx1 was performed on cell lysates from WT HEK-293T
cells and cells ectopically expressing either Panx1 alone or with Panx1-RFP and
Panx1T307-RFP. A robust interaction of the Gly1 and Gly2 species of Panx1-RFP
with Panx1 was revealed when immunoblotted for RFP (A) and Panx1 (B).
Panx1T307-RFP also co-immunoprecipitated with Panx1, however, it was mainly
the Gly1 species that was weakly pulled down (A). Co-immunoprecipitaton of
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Panx1 with Panx1T307-RFP revealed reduced interaction with the Gly2 species of
Panx1 (B). Expression levels of all Panx1 variants were also assessed by
probing the total protein lysate with RFP or Panx1 antibody.
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In contrast, despite detectable Panx1T307-RFP expression in the cell lysates,
NeutrAvidin fractions contained virtually no Panx1T307-RFP (Figure 3.7A).
As a control, the lack of immunolabeling of GAPDH suggests that biotin did not
penetrate into the cell. When co-expressed with Panx1, a subpopulation of the
highly glycosylated species of Panx1-RFP (Figure 3.7B and C), as well as all the
three glycosylation forms of Panx1, reached the cell surface (Figure 3.7C).
However, when co-expressed with Panx1T307-RFP, there was a noticeable
reduction in the cell surface population of all the three species of Panx1 (Figure
3.7C), with no clear evidence of plasma membrane expression of Panx1T307RFP, even in the presence of Panx1 (Figure 3.7B). These findings support the
notion that the Panx1T307-RFP mutant is acting dominantly to reduce the delivery
of Panx1 to the cell surface.

3.3.7 Panx1T307-RFP is preferentially degraded through
the proteasomal pathway
Given the predominant intracellular distribution of Panx1T307-RFP, we assessed
whether Panx1T307-RFP is targeted to proteasomal or lysosomal degradation
using the pharmacological inhibitors lactacystin and chloroquine, respectively.
Blocking the proteasomal pathway with lactacystin clearly showed a robust
accumulation of both the Gly1 and Gly0 species of Panx1T307-RFP, with no
detectable change in protein expression upon chloroquine exposure (Figure
3.8A). On the contrary, inhibition of the lysosomal and not the proteasomal
pathway revealed a pronounced increase in the Gly1 and Gly2 species of both
Panx1-RFP (Figure 3.8A) and Panx1 (Figure 3.8B). In comparison to Panx1
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alone (Figure 3.8B), co-expression with Panx1T307-RFP showed an overall
decrease in the Gly2 species of Panx1, with a noticeable reduction in the Gly1
species, upon chloroquine treatment (Figure 3.8C). When compared to
Panx1T307-RFP alone (Figure 3.8A), co-expression with Panx1 revealed an
accumulation of the Gly1 species of Panx1T307-RFP with the chloroquine
treatment, without considerably altering the expression upon lactacystin
treatment (Figure 3.8C).
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Figure 3.7 Panx1T307-RFP reduces the cell surface expression of Panx1
Protein lysates of HEK-293T cells labeled with (+) or without (-) biotin were
precipitated with NeutrAvidin beads prior to immunoblotting for RFP and Panx1.
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Cell surface biotinylation of Panx1-RFP revealed that all glycosylated species of
Panx1 trafficked to the cell surface, while no clear cell surface expression of
Panx1T307-RFP was detected (A). NeutrAvidin fraction displayed a pronounced
cell surface expression of both Panx1-RFP and Panx1, when co-expressed
together (C). Plasma membrane biotinylation of co-expressed Panx1 could not
detect Panx1T307-RFP at the cell surface (B); however Panx1T307-RFP expression
reduced the overall expression of Panx1 (C). Total protein lysates labeled with
(+) or without (-) biotin were also assessed for expression levels of Panx1,
Panx1-RFP and Panx1T307-RFP. GAPDH (an intracellular protein) was used to
detect any internalization of biotin.
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Figure 3.8 Panx1 is destined for proteasomal-mediated degradation in the
absence of the C-tail
Panx1T307-RFP, Panx1-RFP and Panx1 expressing HEK-293T cells were
exposed to either proteasomal (lactacystin) or lysosomal (chloroquine) inhibitors
for 20 hours prior to immunoblotting for RFP and Panx1. Expression of both the
Gly0 and Gly1 species of Panx1T307-RFP increased with lactacystin exposure,
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with no detectable change upon chloroquine treatment (A). Lactacystin-treated
cells expressing Panx1-RFP (A) or Panx1 (B), revealed a slight reduction in the
expression of the Gly2 species; while chloroquine treatment resulted in the
accumulation of the Gly1 and Gly2 species. Co-expression of Panx1 with
Panx1T307-RFP clearly reduced the Gly2 form of Panx1 (C). When co-expressed
together, chloroquine treatment caused a reduction in the Gly1 form of Panx1,
while Gly1 increased in cells expressing Panx1T307-RFP (C). GAPDH was used
as a protein loading control.

121

3.4 DISCUSSION
To identify the role of the Panx1 C-terminal domain in regulating Panx1
trafficking, glycosylation, oligomerization and degradation, the current study
employed a Panx1 mutant that lacked the last 119 amino acid residues from the
C-terminus.

First we identified that in the absence of the C-terminal tail the

mutant failed to traffic to and be retained at the cell surface. Second, the Panx1
truncated mutant was retained primarily within the ER where it was found as a
core Gly0 protein or a high-mannose Gly1 species. Third, the Panx1 mutant
failed to substantially interact with Panx1 suggesting that the C-terminal domain
plays a role in Panx1 homomeric oligomerization. Finally, the ER-retained
truncated mutant was subjected to proteasomal degradation, which is consistent
with ER associated degradation.

3.4.1 Cell surface trafficking, post-translation
modification and homomeric interaction of Panx1T307RFP
It has been well established that Panx1 traffics to the plasma membrane and
distributes itself in a fairly uniform pattern, with some evidence of cell surface
clustering [153]. Our results revealed that the deletion of the C-tail causes a shift
in Panx1 localization, with a predominant retention in the ER. Similarly, truncation
of the C-tail domain has been shown to perturb the cell surface trafficking of
several other integral membrane proteins such as the human anion exchanger
AE1 [156], the human sodium dependent vitamin C transporter 1 [157], the A1
adenosine G-protein coupled receptor [158] and Glut 1 and Glut 4 isoforms of
glucose transporter [159], thus suggesting that an intact C-tail domain is required
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to facilitate the adequate delivery of several proteins to plasma membrane. In
addition, the cell surface trafficking of Panx1 is partially dependent on
addition/processing of the glycan chains in the ER-Golgi compartments [47, 59].
Therefore, to determine if the lack of the cell surface localization of Panx1T307RFP was related to its glycosylation status we further assessed this possibility.
Our results indicated that Panx1T307-RFP exists as both core (Gly0) and high
mannose (Gly1) species. Given that Panx1 is glycosylated on the second
extracellular loop [25, 47], together with the fact that the Gly1 species of
Panx1T307-RFP was sensitive to Endo H treatment, our data suggests that
deletion of the C-tail does not interfere with normal ER-based glycosylation
events. It is quite likely that the trafficking defect is thus independent of ER-based
glycosylation events but could still be related to proper Panx1 folding or
oligomerization. This notion is somewhat similar to a case involving C-tail
mutants of A1 adenosine G-protein coupled receptors, where incomplete
modifications of the complex carbohydrate chains was correlated with defects in
exiting the ER compartments of HEK-293 cells [158].

In addition, the ER

retention of the C-tail truncated mutants of A1 receptors was also associated with
incomplete folding and failed ER quality control [158]. It is well established that
ER based chaperones, such as calnexin, mediate quality control by aiding in
proper folding of glycoproteins, while restricting the trafficking of misfolded
proteins [160]. In our studies, the strong co-localization of Panx1T307-RFP and not
Panx1-RFP with calnexin could possibly reflect the misfolded state of Panx1 in
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the absence of its C-tail. Alternatively, failure of truncated Panx1 acquiring a
proper oligomeric state could also be the cause for its ER retention [161, 162].
Misfolded mutant proteins often impair cell surface trafficking of their wild-type
counterparts. One of the well characterized examples of this phenomenon is the
ER retention of the Cl- ion channel cystic fibrosis transmembrane conductance
regulator (CFTR) in the presence of its mutant counterpart ∆F508 [163]. Our cell
surface biotinylation assay of cells co-expressing Panx1 and the truncated
mutant did not reveal the mutant at the cell surface; however, the presence of the
mutant clearly reduced the cell surface expression of all the Panx1 species.
Interestingly, a similar ER variant-induced inhibition of the cell surface delivery of
WT members of Wnt receptors was deemed to be due to impaired
oligomerization [164]. Given that Panx1 oligomerizes as a hexamer prior to
trafficking to the cell surface [47], we were interested in investigating if the partial
retention of Panx1 in the presence of the mutant was due to potential cointeractions between the mutant and Panx1, while being residents of the ER.
Interestingly, only a weak interaction between the Gly1 species of Panx1T307-RFP
and full length Panx1 was detected, thus suggesting the importance of the intact
C-tail in mediating efficient oligomerization process of Panx1.

3.4.2 Fate of the C-tail truncated mutant of Panx1
It is widely accepted that misfolded or improperly assembled proteins retained in
the ER are destined for premature degradation, if molecular chaperones are
unable to correct their folding [159]. A proteasomal based degradation pathway is
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linked to the degradation of incorrectly folded glycoproteins that are rejected by
the quality control system of the ER [165], a process termed ER-associated
degradation (ERAD). Proteasomal inhibition-induced accumulation of Panx1 in
our studies, together with its localization in the calnexin-positive ER
compartments suggests that this mutant is likely a substrate for ERAD.
Interestingly and consistent with a study by Boassa et al., [47], our studies
suggest that full length Panx1 is destined for lysosomal degradation.

In

particular, chloroquine-induced lysosomal inhibition of Panx1 revealed an
increase in the more complex-mature form and the high mannose glycosylated
species of Panx1. Since both glycosylated species of Panx1 (complex and high
mannose) are capable of trafficking and residing at plasma membrane [59], its
accumulation suggests that Panx1 cycling through the cell surface are destined
for lysosomes for degradation. Alternatively, since a subpopulation of the high
mannose species of Panx1 is also associated with the ER pool [47], its
accumulation could either be a consequence of a negative-feedback mechanism,
generated from the cell surface pool of Panx1 or inhibition of direct escape from
ER-Golgi compartment to lysosomes. This hypothesis is somewhat supported by
studies showing targeting of mutated prion proteins from the Golgi apparatus to
lysosomes [166].
In keeping with our current findings, we propose a model where full length
Panx1, capable of trafficking to the cell surface, is preferentially destined to
lysosomes, as opposed to proteasomal dependent degradation of truncated
mutant. This paradigm is shifted, however, when Panx1T307-RFP and Panx1 are
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co-expressed. An obvious increase in the high mannose species of Panx1T307RFP and Panx1 is noticed upon lysosomal and proteasomal inhibition,
respectively. It is likely that oligomerization of Panx1 with Panx1T307-RFP drives a
subpopulation of Panx1T307-RFP to lysosomes and a limited proportion of Panx1
to proteasomes.

3.4.3 Pathophysiological Significance
Adequate cell surface trafficking is imperative for Panx1 to form functional single
membrane channels [25, 59]. A recent report showed that a single amino acid
substitution from cysteine to serine at residue 346 on the C-tail alters Panx1
channel properties, such that it leads to the formation of constitutively leaky
channels, thereby causing cell death [152]. Additionally, a point mutation in the
Panx1 C-tail at position 337 perturbs the trafficking and distribution at the cell
surface [47]. The physiological significance of the C-tail is further demonstrated
by other channel forming proteins such as Cx43, where 97% of mice harboring a
truncation of carboxyl-terminal (K258stop) die shortly after birth due to a
defective epidermal barrier caused by impaired differentiation of keratinocytes
[167].

With a growing significance of Panx1 in initiation and propagation of

calcium waves [60], tumor suppression [53], release of interleukin-1β [147],
keratinocyte differentiation [67], and ischemia induced cell death [78], our study
provides strong evidence for a critical role for the carboxyl terminal tail in
regulating Panx1 trafficking, oligomerization and degradation.
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CHAPTER 4: Panx1 Exhibits Prolonged Turnover Kinetics
and Internalization Pattern Distinct from the Connexin
Family of Gap Junction Proteins

4.0 OVERVIEW

This study was designed to uncover the turnover kinetics and mechanism(s)
responsible for Panx1 endocytosis. In particular, endocytic pathways mediated
by clathrin-, caveolin- and dynamin were closely examined to determine their
roles in the internalization of Panx1. A unique pattern of Panx1 turnover was
characterized using rapid time-lapse imaging, while the degradation of Panx1
was explored using pharmacological inhibitors.
_____________________

This chapter is currently in the process of being submitted, while some of the
sections have been published in:

Silvia Penuela, Ruchi Bhalla, Xiang-Qun Gong, Kyle N. Cowan, Steven J.
Celetti, Bryce J. Cowan, Donglin Bai, Qing Shao, and Dale W. Laird
Pannexin 1 and pannexin 3 are glycoproteins that exhibit many distinct
characteristics from the connexin family of gap junction proteins.
J. Cell Sci., 2007. 120(21): p. 3772-3783.
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4.1 INTRODUCTION
Pannexins (Panxs) are the recently identified vertebrate homologues of the
integral membrane invertebrate gap junction proteins, innexins [1, 21]. Although
no sequence homology exists between pannexins and the vertebrate gap
junction proteins, connexins (Cxs), pannexins were first proposed to belong to
the gap junction superfamily of proteins based on their homology to innexins.
Panx and Cxs exhibit tetraspanning transmembrane domains with intracellular
amino and carboxy termini and two extracellular loops [108]. While there are 21
members of the connexin family, the pannexin family is comprised of only three
members: Panx1, Panx2 and Panx3, which are commonly examined in humans,
mice and rats [21]. Similar to Cx43, Panx1 is ubiquitously expressed in several
murine tissues, while Panx2 is expressed predominantly in the central nervous
system, and Panx3 is localized to the skin and cartilage [21, 25].
It has been reported that Panx1 oligomerizes into hexamers that traffic to the
plasma membrane to form cell surface channels [47]. We and others have
demonstrated that Panx1 achieves three states of glycosylation: Gly0 (core,
unglycosylated), Gly1 (high mannose form) and Gly2 (complex form) [25, 47];
and assembles as single membrane channels that are mechano-sensitive [25,
57]. In addition, limited evidence also exists to support the formation of Panx1
intercellular channels [26, 53, 54].
Homomeric single-membrane Panx1 channels have a large conductance of 550
pS [57], which is correlated with ionic dysregulation during ischemic conditions,
subsequently leading to neuronal necrosis [78]. Furthermore, N-methyl-D-
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aspartate receptor (NMDAR)-induced opening of Panx1 channels has been
implicated in hippocampal epileptiform seizure-like activity [66]. Other studies
have associated Panx1 channel activation with apoptosis of Xenopus oocytes by
forming a pore unit with the death complex of the P2X7 receptor [72]. More
recently, Panx1 was characterized as a target for caspase 3 and 7 cleavage that
resulted in a constitutively open channel [79]. In the same study, Panx1 channels
were further shown to mediate phagocyte recruitment by releasing nucleotide
signals from apoptotic cells [79]. In light of several physiological roles for Panx1,
it is critical to determine pathways that may regulate its turnover and degradation.
In the case of Cx43, a unique turnover mechanism exists where gap junction
plaques are internalized into one of the two contacting cells as large double
membrane structures called connexosomes [101]. In addition, several studies
have identified an association between Cx43 and clathrin-coated pits [102-104],
where the down regulation of clathrin-adaptor protein complex 2 (AP2) as well as
dynamin GTPase significantly reduced Cx43 gap junction internalization [102].
Cx43 has been shown to interact with caveolin (Cav)-1 [168] and Cav-2 to form
complexes in membrane rafts at the plasma membrane that further regulate the
level of gap junctional intercellular communication (GJIC) [154]. While more than
one pathway exists in mediating Cx43 turnover, it has yet to be investigated
whether pannexins follow the same routes of internalization.
We and others have reported that Panx1 exhibits slower turnover rates than
Cx43 [25, 81]. While Cx43 biosynthesis, cell surface delivery, removal from the
plasma membrane and degradation is completed with a half-life of only 1-3 hours
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[82], use of pharmacological blockers have suggested that Panx1 levels at the
cell surface remain relatively unchanged over a period of 8 hours [25]. Rapid
turnover kinetics for Cx43 is of physiological importance for cell and tissue
homeostasis through the regulation of GJIC. This notion is clearly demonstrated
by a several fold increase in Cx43 expression in the myometrium prior to the
labor onset, followed by rapid clearing post labor [169, 170]. Similarly, it is
hypothesized that Panx1 turnover kinetics may also be critical in governing key
physiological roles in cells. While Cx43 is targeted for both lysosomal and
proteasomal degradation [105, 106, 171, 172], one report has suggested that
Panx1 is destined for lysosomal degradation [47]. However, it is not currently
known which glycosylated species of Panx1 undergoes lysosomal-mediated
degradation. Thus, in the current study, we examine whether dynamin- and/or
caveolin-dependent pathways are involved in Panx1 internalization, how Panx1
internalizes as assessed by rapid time-lapse imaging, and which Panx1 species
are destined for lysosomal degradation.
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4.2 EXPERIMENTAL PROCEDURES
4.2.1 Cell culture and reagents
BICR-M1Rk cells, originally derived from rat mammary tumors, were a gift from
Dieter Hulser, (Stuttgart, Germany [96]) and engineered to stably over-express
Panx1, as previously described [25]. Cells were maintained at 37°C in high
glucose DMEM (Invitrogen, Burlington, ON, Canada), supplemented with 10%
fetal bovine serum, 100 units/ml penicillin, 100 µg/ml streptomycin, and 2 mM Lglutamine (all from Invitrogen, Burlington, ON, Canada), and sub-cultured using
0.25% trypsin/1 mM EDTA solution (Invitrogen).

4.2.2 Transfections
GFP-tagged WT and K44A DynII expression constructs were kindly provided by
Dr. Mark A McNiven, (Mayo Clinic College of Medicine, MN) and used for
conducting transient transfections of BICR-M1Rk cells expressing Panx1. Cells
grown in 35 mm dishes overnight to ~50-70% confluency were transfected in
Opti-MEM1 media containing 1 µg of WT or K44A DynII GTPase cDNA
constructs with 2 μL Lipofectamine 2000. Opti-MEM1 media was replaced with
complete media 4 hrs post transfection.

4.2.3 Immunocytochemistry
Panx1 expressing BICR-M1Rk cells grown overnight on glass coverslips were
fixed with either 3.7% formaldehyde or 80% methanol and 20% acetone.
Formaldehyde fixed cells were permeabilized in 1% blocking solution (Bovine
Serum Albumin-(BSA; Sigma)) containing 0.1% Triton-X-100. Since antibodies
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against Panx1, clathrin and Cav-1 were all raised in rabbits, a 488 fluorophore
conjugated Panx1 antibody was engineered as per manufacturer’s directions
(Pierce Chemical) for dual labeling of Panx1 with these markers. For
immunolabeling of Panx1 expressing cells for clathrin or Cav-1, cells were first
incubated with either a 200 fold dilution of polyclonal anti-clathrin heavy chain
antibody (Abcam), or a 100 fold dilution of polyclonal anti-Cav-1 antibody (BD
Biosciences Transduction Laboratories) for 1 hr at room temperature, followed by
incubation with goat anti-rabbit Alexa Fluor555 (1:500, Invitrogen) for 45 min at
room temperature. Thereafter, cells were washed with PBS and incubated with
Panx1_488 antibody for an additional 45 min at room temperature before staining
nuclei with Hoechst 33342 (Invitrogen). For double labeling of Panx1 expressing
cells for AP2 or Cav-2: cells were first labeled with affinity-purified polyclonal
Panx1 antibody at a concentration of 2 μg/mL for 1 hr, followed by incubation
with goat anti-rabbit Alexa Fluor555 (1:500, Invitrogen) for 45 min at room
temperature. Next, cells were labeled with either monoclonal anti-AP2 (Sigma) or
monoclonal anti-Cav-2 (BD Biosciences Transduction Laboratories) at a 100 fold
dilution followed by incubation with goat anti-mouse Alexa Fluor488 (1:500,
Invitrogen). DynII was labeled using a 50 fold dilution of anti-DynII antibody
(Santa Cruz) for 1 hr prior to using Texas Red conjugated donkey anti-goat
(1:200, Jackson Immuno Research Laboratories) as a secondary antibody. Once
immunolabeled, cells were mounted on glass slides and imaged using a LSM
510 META confocal microscope (Zeiss) using a 63x oil lens.
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4.2.4 Pharmacological inhibitors
Brefeldin A (BFA), cycloheximide (CHX), dynasore, methyl-β-cyclodextrin (MβC)
and chloroquine were all purchased from Sigma. Cells were treated for 20-32 hr
with 5 µg/ml BFA and for 1-24 hr with 10 mM MβC. For cycloheximide treatment,
20 µg/ml was used to inhibit all protein synthesis, and cells were lysed at 2, 4, 6
and 8 hours following the exposure. Dynasore treatment was used at a
concentration of 40 µM, consistent with previous studies [102]. Post treatment,
cells were fixed for immunocytochemistry and lysed for immunoblotting and coimmunoprecipitation assays.

4.2.5 Immunoblotting and co-immunoprecipitation
Immunoblotting and co-immunoprecipitation assays were performed based on
our previously described protocol [153]. Briefly, cells were lysed in buffer
containing 150 mM NaCl, 10 mM Tris-HCl, pH 7.4, 1 mM EDTA, 0.5% NP-40,
and 1% Triton X-100, supplemented with protease inhibitor cocktail (one tablet
per 10 mL buffer, Roche) and phosphatase inhibitors (1 mM NaF and 1 mM
Na3VO4). Protein concentrations were measured using a BCA protein
determination kit (Pierce), and 20-30 µg of total protein lysate was resolved on a
10% SDS-PAGE gel.

Protein samples were transferred onto nitrocellulose

membranes using the iBlot Dry Blotting system (Invitrogen) and blocked with 5%
Blotto Milk (Santa Cruz Biotechnologies) or 3% BSA (Sigma) for 1 hr prior to
incubating with anti-Panx1 (0.2 µg/mL), anti-clathrin (1:1000, Abcam), anti-AP2
(1:500, Sigma), anti-DynII (1:250, Santa Cruz), anti-Cav-1 (1:2000) or anti-Cav-2
(1:2000 BD Biosciences Transduction Laboratories), and anti-GAPDH (1:5000,
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Millipore) antibodies. Primary antibody binding was detected using mouse IgG IR
dye 800 at 1:10,000 dilution (Rockland Immunochemicals) or rabbit IgG Alexa
680 at 1:10,000 dilution (Invitrogen) and blots were scanned with the Odyssey
infrared imaging system (Licor).
For co-immunoprecipitation assays, 800-1000 µg of cell lysates were incubated
overnight in presence of 10 µg/ml anti-Panx1 antibody at 4°C, and immune
complexes were pulled down using 30 µl (50% suspension) of protein ASepharose beads. Beads were washed in 1x lysis buffer, boiled for 5 min in 30 µl
of 2x Laemmli buffer, resolved by SDS-PAGE, and immunoblotted with specific
antibodies to detect Panx1, clathrin, AP2, Cav-1, Cav-2 and DynII. Although
primary antibodies were detected using mouse IgG IR dye 800 at 1:10,000
(Rockland Immunochemicals) or rabbit IgG Alexa 680 at 1:10,000 (Invitrogen),
detection of co-immunoprecipitates was achieved using the Clean-Blot IP
Detection Reagent (horse radish peroxidase; Pierce Chemical) as a secondary
antibody at a 4000 fold dilution for 45 minutes, in order to minimize the
appearance of the IgG bands in some instances.

4.2.6 Transferrin uptake
Cells expressing WT DynII or K44A mutant grown on glass bottom dishes were
rinsed and incubated in DMEM media containing 20 mM Hepes and 2 mg/ml
BSA for 1 hr at 37°C. Cells were incubated for 1 hr in presence of 10 µg/ml of
dynasore. Media was then replaced with media containing 10 µg/ml of
transferrin-Alexa 555 (Invitrogen) and cells were incubated for additional 45 min
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at 4°C to block any uptake. Thereafter, cells were imaged either immediately (to
capture 0 min of uptake) or post 30-40 min after incubation at 37°C.

4.2.7 Rapid time-lapse imaging
BICR-M1Rk cells expressing GFP-tagged Panx1 were sub-cultured on glass
bottom dishes and treated with 5 µg/ml of BFA in culture media for 20 hr at 37°C.
Prior to imaging, cells were rinsed and replenished with Opti-MEM1 media
containing fresh BFA. Rapid time-lapse imaging was performed in a temperature
and C02 controlled humidity chamber, staged on a Zeiss LSM 510 META
confocal microscope. A region of interest was selected and vesicles budding
from the plasma membrane were monitored at 30 s time intervals for a total
period of 23 min.
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4.3 RESULTS
4.3.1 Panx1 exhibits a longer turnover rate than Cx43
We have previously demonstrated that Cx43-positive BICR-M1Rk cells serve as a
good cell reference model for examining the turnover mechanisms of Cx43 [109],
and thus this cell system has been employed in this study to investigate the
internalization process of Panx1. In order to follow the fate of an existing cell
surface population of Panx1, we used BFA to block the transport of newly
synthesized proteins to the plasma membrane. BFA-treated cells overexpressing Panx1 were fixed at various time points prior to immunolabeling for
Cx43 and Panx1. In untreated cells, Cx43 was visualized as punctate structures
at cell-cell appositions with some intracellular distribution, whereas Panx1 was
localized in a relatively uniform pattern at the cell surface (Figure 4.1A). Within 3
hrs of BFA exposure, most of the Cx43 puncta were cleared from the cell surface
and newly synthesized protein was retained in an ER-like pattern. In contrast,
Panx1 was localized predominantly at the cell surface with minimal distribution in
the intracellular compartment (Figure 4.1A). At 32 hrs of BFA treatment, some
clearing of Panx1 from the cell surface was evident with increased accumulation
in an ER-like pattern (Figure 4.1A). To further compare the kinetic properties
between pannexins and connexins, Panx1 and Cx43 expression was examined
in cells under conditions in which protein synthesis was inhibited by CHX.
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Figure 4.1 Turnover kinetics of Cx43 and Panx1
Panx1 expressing, Cx43-positive BICR-M1Rk cells were treated with BFA for up
to 32 hr prior to immunolabeling for Cx43 or Panx1 (A, red). Note the loss of
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Cx43 from the cell surface within 3 hr of BFA treatment while Panx1 was
observed at the cell surface for over 18 hr. Nuclei were stained with Hoechst.
Bar=10µm. Cells exposed to CHX for 2, 4, 6 and 8 hr were immunoblotted for
Panx1 and Cx43 (B). When compared to untreated cells (0 hr), immunoblot
analysis of Panx1 revealed no difference between the banding profile at 2, 4, 6
and 8 hr of CHX treatment (B); whereas, the level of Cx43 consistently
diminished following CHX exposure (B). Upon BFA treatment, Panx1 revealed
the accumulation of the Gly1 species with a reduction of the Gly2 species, which
remained the same for up to 5 hr upon BFA washout (B). β-actin and GAPDH
were used as protein loading controls.
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In agreement with the BFA results and when compared to untreated cells,
immunoblot analysis of Panx1 levels revealed no difference between the banding
profiles at 2, 4, 6 and 8 hrs of CHX treatment (Figure 4.1B), whereas there was
an overall time-dependent decrease in Cx43 levels following CHX exposure
(Figure 4.1B). These results clearly suggest Panx1 retention at the cell surface is
much longer than Cx43.
The rapid turnover and intracellular accumulation of Cx43 can be reversed within
1 hr of BFA removal [109]. Based on this information, we investigated if the
recovery dynamics of Panx1 BFA treatment was the same as Cx43 or different.
BFA treatment of Panx1 expressing cells for 20 hrs reduced the higher
glycosylated (Gly2) species, with a subsequent increase in the high mannose
(Gly1) form of Panx1 (Figure 4.1C). However, 5 hr washout of BFA was
insufficient to return the ratio of the three Panx1 glycosylated species back to
normal (Figure 4.1C). Collectively, these results suggest that not only is Panx1
long lived at the cell surface but trafficking of Panx1 through the secretory
pathway is relatively slower than that of Cx43.

4.3.2 Panx1 is co-expressed but does not coimmunoprecipitate with clathrin or AP2
Clathrin mediated endocytosis (CME) is a well documented process that is
initiated by the recruitment of clathrin and adaptor proteins (such as AP2) to the
plasma membrane before forming a coat around the endocytic vesicles and
budding off [173]. Internalization of Cx43 has previously been correlated, in part,
with the CME pathway [102]. In order to investigate if Panx1 is internalized
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through a clathrin driven pathway, we first immunolabeled Panx1 expressing
BICR-M1Rk cells with antibodies directed against the clathrin heavy chain and
Panx1. Panx1 was distributed at the cell surface in a relatively uniform pattern;
while, clathrin was assembled in a punctate-like pattern at the cell surface with
some intracellular distribution (Figure 4.2A). Panx1 co-distributed with clathrin
(Figure 4.2A) and AP2 (Figure 4.2B) at the cell surface. The plasma membrane
co-distribution of Panx1 with AP2 was not noticeably altered in the presence or
absence of BFA (Figure 4.2B and C). Additionally, immunoprecipitation of Panx1
from WT and Panx1 over-expressing cells did not pull down either clathrin or
AP2, which were expressed in total lysates at ~180 kDa and ~105-110 kDa,
respectively (Figure 4.2D). As expected, Panx1 was immunoprecipitated in cells
over-expressing Panx1 but not in WT cells (Figure 4.2D). This indicates that
although Panx1 may co-exist in the same compartment with either clathrin or
AP2, they do not interact.

4.3.3 Panx1 co-distributes but does not coimmunoprecipitate with Cav-1 and Cav-2
Several channels have been reported to localize to the lipid rafts/ caveolae to
regulate their functional status [174-176]. Caveolae are specialized invaginated
domains that are formed by the caveolin family of integral membrane proteins,
which consists of three members: Cav-1, Cav-2 and Cav-3 [177]. Similar to
Panx1, Cav-1 is ubiquitously expressed in several tissues, whereas Cav-2 is coexpressed with Cav-1 in various tissues and Cav-3 is primarily restricted to
muscle [178].
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Figure 4.2 Panx1 co-distributes, but does not co-Immunoprecipitate with
clathrin or AP2
Panx1 expressing BICR-M1Rk cells were immunolabeled for clathrin heavy chain
(A) or anti-AP2 (B, C). 488-fluorophore conjugated Panx1 antibody detected
Panx1 (green) with clathrin (red) at the cell surface (A, merge). Double
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immunofluorescent-labeling revealed the co-distribution of Panx1 (green) with
AP2 (red) at the cell surface before and after a 20 hr BFA exposure (C). Nuclei
were stained with Hoechst. Bar=10µm. Immunoprecipitates of Panx1 from WT
and Panx1 expressing cells were immunoblotted for Panx1, clathrin and AP2.
Panx1 (~43-50kD) was successfully pulled down from Panx1 expressing cells
(under and below the IgG band); however, clathrin (~192kD) or AP2 (~105110kD) did not co-immunoprecipitate with Panx1 (B). IB: immunoblot; IP:
immunoprecipitation, WT: wild type cells; Panx1: Panx1 expressing cells.
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In order to determine whether caveolins play a role in Panx1 turnover, we
investigated the localization profile and interaction status of Panx1 between Cav1

and

Cav-2.

Two

different

fixative

methods,

formaldehyde

and

acetone/methanol, were employed to detect the intracellular and cell surface
populations of Cav-1/Cav-2, respectively [154]. In formaldehyde fixed cells,
Panx1 co-distributed with Cav1 (Figure 4.3A) and co-localized with Cav-2 (Figure
4.3C) in the intracellular compartment, presumably the Golgi complex.
Conversely, fixation with acetone/methanol revealed co-expression of Panx1 with
Cav-1 (Figure 4.3B) and Cav-2 (Figure 4.3D) mainly at cell-cell appositions. To
examine the potential interaction of Panx1 with Cav-1 and Cav-2, a coimmunoprecipitation assay was conducted. Panx1 but not Cav-1 was pulled
down in the immunoprecipitates of Panx1 (Figure 4.3E). Reciprocally, Cav-1 but
not Panx1 was detected in the immunoprecipitates of Cav-1 (Figure 4.3F). While
Panx1 was detected in the immunoprecipitates of Panx1 expressing cells, Cav-2
remained undetected (Figure 4.3G). Conversely, Cav-2 but not Panx1 was
expressed in the immunoprecipitates of Cav-2 (Figure 4.3H). As expected, total
cells lysates revealed Panx1 expression only in over-expressing and not the WT
cells, whereas Cav-1 (Figure 4.3E and F) and Cav-2 (Figure 4.3G and H) were
detected in both WT and Panx1 over-expressing cells.
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Figure 4.3 Subcellular distribution and interaction of Panx1 with Cav-1 and
Cav-2
BICR-M1Rk cells endogenously expressing Cav-1 and Cav-2, and stably
expressing Panx1 were fixed with formaldehyde or acetone/methanol prior to
immunolabeling. Panx1 (green) was found to co-distribute with intracellular and
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plasma membrane localized Cav-1 and Cav-2 (red) (A-D).

Immunoprecipitates

of Panx1 (E and G) from WT and Panx1 expressing cells were immunoblotted for
Panx1, Cav-1 and Cav-2. Panx1 was detected only in the immunoprecipitates of
Panx1 (E and G) and not in the Cav-1 (F) or Cav-2 (H) immunoprecipitates.
Conversely,

Cav-1(F)

and

Cav-2

(H)

were

found

in

their

respective

immunoprecipitates and not in the Panx1 immunoprecipitates (E and G). IB:
immunoblot; IP: immunoprecipitation, WT: wild type cells; Panx1: Panx1
expressing cells.
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While caveolins become detergent insoluble upon integrating into membrane
rafts, these rafts can be disrupted with the cholesterol-depleting agent MβC
[154]. We exposed Panx1 expressing cells to MβC for various time points to
disrupt caveolin enriched membrane rafts. No substantial difference in the Panx1
banding pattern (Figure 4.4A) or localization profile (Figure 4.4B) was detected in
presence of MβC. Interestingly, the highly phosphorylated species of Cx43,
typically associated with the cell surface and detergent-insoluble pool [154],
diminished within 1 hr of MβC treatment (Figure 4.4A). Overall, our results
indicate that while Panx1 co-distributes in the same intracellular and cell surface
compartments as Cav-1 and Cav-2, there is no clear evidence of their cointeraction. Additionally, cholesterol extraction from the plasma membrane does
not noticeably alter the overall Panx1 expression.

4.3.4 Panx1 internalization is independent of dynamin
GTPase
The dynamin GTPase is a common player in mediating caveolar fission, as well
as budding the clathrin coated vesicles from the plasma membrane [179]. The
mammalian dynamin family comprises of three members: dynamin I, II and III,
where dynamin I is brain-enriched, dynamin II is ubiquitously expressed and
dynamin III is mainly found in testis but also has some enrichment in brain
especially in postsynaptic areas [180-183]. It is well accepted that a dominantnegative GTP hydrolyzing mutant of dynamin (K44A) interferes with the function
of endogenous dynamin by blocking vesicular internalization prior to pinching off
cell membrane [184]. Therefore in order to investigate the role of dynamin in
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Figure 4.4 Characterization of methyl-β-cyclodextrin treatment on Panx1
expression levels and distribution profile
Western blots revealed that the expression levels of the Panx1 glycosylation
species remained unaltered after a 24 hr treatment with MβC (A); while the highly
phosphorylated form of Cx43 was reduced within 1 hr of MβC exposure (A). The
cell surface distribution of Panx1 (red) remained relatively uniform during the 24
hrs of MβC treatment (B). Nuclei were counterstained with Hoechst. Bar=10µm.
GAPDH was used as a protein loading control.
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Panx1 internalization, we transfected previously generated GFP-tagged WT and
K44A DynII in Panx1 over-expressing cells. As expected, an antibody generated
against DynII detected both the WT (Figure 4.5A) and K44A DynII mutant (Figure
4.5B), dispersed intracellularly and at the cell surface. Some evidence of Panx1
co-localization with the WT (Figure 4.5C) and the K44A (Figure 4.5D) DynII
mutant at the plasma membrane was noticed in untreated cells. Cells coexpressing Panx1 and WT DynII revealed consistent co-distribution at the cell
surface with a slight increase in the intracellular localization of Panx1 (Figure
4.5E). Conversely, in the presence of BFA, cells co-expressing Panx1 and the
K44A DynII mutant revealed less intracellular accumulation of Panx1 when
compared to cells expressing only Panx1 in the same culture environment
(Figure 4.5F). It was unclear if the increased intracellular expression of Panx1 in
the absence of the K44A DynII mutant was due to uninhibited turnover of the cell
surface population of Panx1 or the BFA-induced ER accumulation of Panx1.
Therefore, we assessed the effect of the WT and K44A DynII mutant overexpression, and dynasore (a pharmacological inhibitor of dynamin GTPase) on
the glycosylation species of Panx1. It was predicted that if dynamin GTPase
plays a role in Panx1 internalization, then an increase in the Gly2 expression of
Panx1 would be seen in the presence of the K44A DynII mutant or dynasore. In
the untreated group, expression of Panx1 alone or in presence of the WT or
K44A DynII revealed no significant difference among all the three glycosylated
species of Panx1 (Figure 4.6A and B). In contrast, BFA treatment significantly
reduced the Gly2 species with a subsequent increase in the Gly1 species of
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Figure 4.5 Assessment of Panx1 distribution in the presence of WT and
K44A mutant DynII
Cells stably expressing Panx1 were transiently transfected with WT or K44A
DynII expression constructs. Immunolabeling with anti-DynII antibody (red)
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detected the GFP-tagged WT (green) and K44A (green) DynII mutant at the cell
surface and within intracellular compartments (A and B). In untreated cells, WT
and K44A DynII localized with Panx1 primarily at the cell surface (C and D). BFA
treatment induced similar intracellular and cell surface distribution of Panx1 in the
presence of WT (E) or K44A DynII (F). Nuclei were counterstained with Hoechst.
Bar=10µm.
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Figure 4.6 Characterization of dynamin GTPase on Panx1 expression,
interaction and transferrin uptake
Protein lysates of untreated and BFA treated cells expressing Panx1 alone or in
combination with WT and K44A DynII, were subjected to immunoblotting using
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anti-Panx1 and anti-DynII antibodies. A significant reduction of the Panx1 Gly2
species and accumulation of the Gly1 species was observed when cells were
exposed to BFA (A and B). The overall Panx1 expression levels remained
unaltered with the co-expression of WT and K44A DynII (A and B). Transient
transfection of WT and K44A DynII resulted in their expression at approximately
equal levels (A). In contrast to the WT DynII, temperature sensitive uptake of
transferrin-Alexa 555 in live cells was greatly reduced in the presence of K44A
DynII (C). Immunoprecipitates of Panx1 from WT and Panx1 expressing cells
were probed with anti-Panx1 and anti-DynII antibodies. Panx1 but not DynII was
detected in the immunoprecipitates of Panx1 (D). GAPDH was used as a protein
loading control. For statistical analysis, ratios between glycosylation species of
Panx1 (Gly0, Gly1, Gly2) and GAPDH loading control were taken and a one-way
ANOVA was performed followed by Tukey’s post test (where ‘a’ is significantly
different to ‘b’ and ‘c’). Y-axis reflects arbitrary numbers. Bar=10µm.
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Panx1 in all groups (Figure 4.6A and B). In comparison to the WT DynII, no
significant increase in the Gly2 species of Panx1 was observed when coexpressed with the K44A DynII (Figure 4.6A and B).
To ensure that cells adequately expressed functional exogenous DynII
constructs, we assessed the protein levels and transferrin uptake capabilities of
the WT and K44A DynII. Over-expression of the GFP-tagged WT and K44A
DynII revealed a band at approximately 125-130 kDa (Figure 4.6A). When
maintained at 4°C, live cells expressing WT or K44A DynII revealed transferrin
distribution at cell-cell appositions (Figure 4.6C). Following incubation at 37°C,
the WT DynII showed a clear accumulation of transferrin in the intracellular
compartment, while K44A DynII restricted the ability of transferrin uptake (Figure
4.6C). Given the role of dynamin in vesicular budding [184], it was not surprising
to find that Panx1 did not interact with DynII (Figure 4.6D). Parallel with the DynII
K44A study, treatment with dynasore alone did not significantly enhance the
expression of the Panx1 Gly2 species (Figure 4.7A and B). When treated
together with BFA, dynasore did not show any additive effect on the BFA-induced
expression levels of the Panx1 Gly2 and Gly1 species (Figure 4.7A and B). As
expected, dynasore treatment limited the transferrin uptake when incubated at
37°C (Figure 4.7C). Overall, our results indicate that Panx1 internalization is
unique and independent of the dynamin-mediated pathway.
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Figure 4.7 Panx1 protein expression levels remains unaltered in the
presence of dynasore
Panx1 expressing cells were treated in the presence or absence of dynasore
together with or without BFA for 20 hrs prior to immunoblotting for Panx1.
Treatment with BFA alone caused a significant reduction in the Gly2 species of
Panx1 with a marked accumulation of the Gly1 form; while dynasore treatment
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alone did not change this protein banding profile (A and B). Together, dynasore
did not cause any additive effect to the BFA induced reduction and accumulation
of the Gly2 and Gly1 expression, respectively (A and B). GAPDH was used as a
protein loading control. Exposure to dynasore successfully blocked the uptake of
transferrin-Alexa 555 in live cells at 37°C (C) indicating its effectiveness at
inhibiting endocytosis. For statistical analysis, ratios between glycosylation
species of Panx1 (Gly0, Gly1, Gly2) and GAPDH loading control were taken and
a one-way ANOVA was performed followed by Tukey’s post test (where ‘a’ is
significantly different to ‘b’ and ‘c’). Y-axis reflects arbitrary numbers. Bar=10µm.
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4.3.5 Panx1 follows a unique pattern of internalization
To examine the internalization of Panx1 in live cells, we exposed Panx1-GFP
over-expressing BICR-M1Rk cells to BFA for 20 hrs prior to capturing rapid-time
lapse images.
BFA treatment revealed three distinct distribution profiles of Panx1: a)
intracellular accumulation around the perinuclear region, b) some evidence of
uniform distribution at the cell surface, and c) bright clusters at the plasma
membrane (Figure 4.8). Over time, bright clusters of Panx1-GFP at the cell
surface formed peculiar tubular-like extensions that stretched away from the
plasma membrane toward intracellular compartments (Figure 4.8 arrowhead, see
Movie 4.1). Additionally, Panx1-GFP containing extensions (570 s, Figure 4.8)
appeared to collapse back onto the plasma membrane (720 s, Figure 4.8).
Overall, these tubular-like extensions were very slow in internalizing from the cell
cell surface ranging from ~ 30-45 mins.

Over 30 tubular-extensions were

visualized in 12 random cells assessed over three independent BFA exposures
and image capturing sessions. Our imaging data suggests that Panx1 is removed
from the cell surface along unique tubular-like extensions.

4.3.6 Panx1 is destined for the lysosomal mediated
degradation
In contrast to untreated cells, long term exposure to the pharmacological
lysosomal inhibitor, chloroquine, revealed a sustained expression of the cell
surface associated Gly2 species, with a pronounced accumulation of the Gly1
form of Panx1 (Figure 4.9). The subcellular distribution of Panx1 in the presence

157

Figure 4.8 Panx1-GFP internalizes in dynamic tubular-like extensions
Cells stably expressing Panx1-GFP were treated with BFA for 20 hrs prior to
performing rapid-time lapse imaging in the presence of BFA. Images were
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acquired every 30 s for the total time of 23 min, however, only a subset of time
frames are displayed (see Movie 4.1). Panx1-GFP internalized by clustering at
the plasma membrane (420 s) followed by a dynamic tubular-like extension
(arrowhead, 450s) that stretched to bud away from the cell surface towards the
intracellular compartment (600-930s). Minimal extensions of other nearby cluster
(unfilled arrow, 570 s) were noticed to collapse back on to the cell surface
instead of detaching itself (720 s). Bar=10µm.
Movie 4.1 Panx1-GFP follows a unique pattern of internalization through
dynamic tubular-like extensions
Rapid time-lapse images of BFA-treated Panx1-GFP expressing cells were
captured to assess the mechanisms of Panx1 internalization. Panx1-GFP was
localized in a relatively uniform manner with some evidence of bright clustering at
the cell surface that occurred prior to endocytosis. These clusters first extended
in a tubular-like morphology away from the cell surface and then detached. The
movie sequence was captured every 30 s over 46 frames representing a total
elapsed time of 23 min. The movie was accelerated to play in 10.12 s.
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of chloroquine paralleled its banding profile, as a sub-population was noticed
around the perinuclear region (presumably lysosomes [47]), with a clear
evidence of the cell surface expression (Figure 4.9). As expected, BFA treatment
reduced the Gly2 species with a subsequent increase in the Gly1 form of Panx1
(Figure 4.9), which was consistent with the loss of the cell surface distribution
coinciding with an accumulation in an intracellular compartment (Figure 4.9).
Inhibition of the lysosomal pathway in the presence of BFA resulted in a slight
increase in expression of the Panx1 Gly2 species when compared to BFA
treatment alone (Figure 4.9). This finding suggests that accumulation of the
existing cell surface pool of Panx1 is a result of blocking its internalization and
degradation through the lysosomal pathway.
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Figure 4.9 Panx1 is degraded by lysosomes
Panx1 expressing cells were exposed to BFA and the lysosomal inhibitor
(chloroquine) alone or together for 20hr prior to immunoblotting (A) and
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immunolabeling (B) for Panx1.

Chloroquine treatment caused a sustained

expression of the Gly2 species of Panx1 with an accumulation of the Gly1 form
(A) which was marked by a increased intracellular distribution of Panx1(B, red).
BFA-induced reduction of the Panx1 Gly2 species (A) was correlated by the
increased loss of the cell surface population of Panx1 with a subsequent
accumulation in the intracellular compartment (B, red). When treated together, a
subtle rescue of the Panx1 Gly2 species was observed in the presence of the
lysosomal inhibitor, chloroquine (A). BFA treatment along with chloroquine also
resulted in the increased cell surface distribution of Panx1 (B, red). GAPDH was
used as a protein loading control. Nuclei were counterstained with Hoechst.
Bar=10µm.
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4.4 DISCUSSION
The focus of this study was to elucidate the turnover kinetics and mechanisms for
internalization and degradation of Panx1. Our data strongly indicates that Panx1
has a long life at the cell surface, follows a unique pattern of internalization that is
independent of endocytic pathways mediated by clathrin, caveolins and dynamin
GTPase, and undergoes lysosomal-based degradation.
One of the distinguished characteristics of most connexin family members is that
their physiological regulation is not only at the level of gating the channels open
or closed [58] but also at the level of gap junction formation and removal [13].
The latter level of regulation is possible because most connexins, including Cx43,
have an unprecedented short half-life for polytopic plasma membrane proteins. In
this regard, our studies in which protein synthesis or trafficking were blocked by
pharmacological agents revealed prolonged localization of Panx1 at the cell
surface, compared to Cx43 gap junctions. Thus, indicating that Panx1 has a
much longer half-life than Cx43.
While the highly phosphorylated P2 form of Cx43 [109] is often identified at the
plasma membrane, it is predominantly the complex glycosylated Gly2 form of
Panx1 [47, 59] that is destined for cell surface delivery. The rapid turnover of
Cx43 in response to BFA is correlated with the loss of the highly phosphorylated
(P2) species with an accumulation of the lower species (P0) of Cx43 [109]. In our
studies, a parallel phenomenon occurred where the high mannose Gly1 species
of Panx1 increased at the expense of the Gly2 species. Since it was possible to
rescue the trafficking of intracellular accumulated Cx43 and rebuild the normal
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gap junction complement upon BFA removal [109], we wanted to follow the
glycosylation status of Panx1 upon BFA washout as a measure of its recovery
from intracellular retention. Interestingly, at no time following BFA removal did
Panx1 levels at the cell surface return to normal, suggesting that Panx1 has
delayed trafficking to the cell surface.

Alternatively, it is possible that the

prolonged exposure to BFA permanently impairs the reorganization of the Golgi
apparatus thus limiting the rescue of the Panx1 Gly2 expression. Nonetheless,
our data strongly supports the conclusion that Panx1 half-life while at the cell
surface is many hours longer than what is documented for Cx43.
While the internalization mechanisms of connexins, particularly Cx43, have been
extensively studied, the endocytic pathways governing Panx1 turnover have not
yet been identified. Whereas, internalization of Cx43 as double membrane
structures [101] termed connexosomes [13] has previously been linked to the
CME pathway, while our study is the first to investigate the role of clathrin in
Panx1 endocytosis. Our data indicates that although Panx1 co-distributes in the
same cell surface micro-domain as clathrin, its physical interaction with the
clathrin heavy chain could not be detected. Consistently, while AP2 co-distributed
with Panx1 at the cell surface they also failed to interact. These finding are in
contrast to other channels types such as chloride channels [185] or renal outer
medullary K+ channels (ROMK) [186], where clathrin-mediated internalization is
marked by co-localization and co-interaction with clathrin and AP2. Since our
study only revealed localization of Panx1 and AP2 in the same compartment
without direct interaction, it is likely that Panx1 endocytosis is independent of
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clathrin and thus distinct from Cx43 and other channel forming proteins. As there
is growing evidence of clathrin-independent pathways for internalization of
plasma membrane proteins that rely on caveolae and glycolipid rafts [187], our
next approach was to identify if Panx1 turnover is mediated by caveolin-driven
pathway.
Several channels such as K+ [188], Ca2+ [189] and Cl- [190] are reported to
localize to glycolipid rafts/caveolae for their regulation by caveolins. Our first
assessment revealed localization of Panx1 with Cav-1 and Cav-2 at the cell
surface and within intracellular compartments.

While the plasma membrane

localization of Panx1 with Cav-1 and Cav-2 suggests the presence of Panx1 in
the lipid rafts- presumably in preparation for internalization, the formaldehydefixed detection of Panx1 with Cav-1 and Cav-2 in the intracellular compartment
argues for a distinct role. In the case of Cx43, the intracellular distribution with
Cav-1 and Cav-2, suggested that caveolins might facilitate the delivery of Cx43
from the Golgi apparatus to cell surface [154]. It is possible that, like Cx43,
caveolins might be involved in the secretory pathway of Panx1. Alternatively,
intracellular co-distribution of caveolins with Panx1 could also reflect the role of
caveolins in recycling Panx1 from the cell surface to the perinuclear region. This
notion is in keeping with the previously reported caveolin-mediated internalization
of the seven transmembrane receptor protein: autocrine motility factor from the
plasma membrane and its targeting to the ER compartment [191, 192].
Interestingly, Cav-1 has been identified as a negative regulator of the endocytic
pathway to the ER compartment, thus providing a more stabilizing role of
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caveolae at the plasma membrane [187]. The reduced intracellular localization of
Panx1 with Cav-1 (in comparison to Cav-2) could support the role of Cav-1 in
maintaining Panx1 at the cell surface instead of its internalization-an argument
that clearly needs further investigation. Our study has shown that distinct from
Cx43, Panx1 does not interact with Cav-1 or Cav-2 [154]. Furthermore, the
cholesterol depleting agent, MβC, known to disrupt the integrity of membrane
rafts [193] and association of Cx43 with Cav-1/Cav-2 [154], did not noticeably
alter the Panx1 expression or its cell surface localization. Taken together, our
results suggest that turnover of Panx1 is independent of caveolin driven pathway.
As large dynamin GTPase (~100 kDa) has implications in clathrin-dependent
internalization [194], and caveolar driven fission of the plasma membrane [195],
we investigated if this molecular player could contribute in Panx1 endocytosis.
To identify the role of dynamin GTPase in Panx1 internalization, we utilized the
GTP binding and hydrolyzing mutant, K44A DynII, in the presence or absence of
BFA. Although Panx1 co-distributed with K44A DynII at the cell surface, blocking
of the ER-Golgi transport with BFA did not reveal a substantial accumulation of
Panx1 at the cell surface. It was also interesting to observe that while K44A DynII
and dynasore blocked the expected transferrin uptake, it did not significantly
increase the expression of the cell surface species of Panx1. This finding differs
from the previously documented accumulation of Cx43 plaques [102], and
enhancement of ROMK (renal outer medullary potassium) channel currents in
response to K44A DynII over-expression [186]. Thus, our data suggests that
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Panx1 is internalized in a unique manner that is independent of dynamin
GTPase.
Our rapid time-lapse imaging of Panx1-GFP following a long term exposure to
BFA suggested that clustering of Panx1 at the cell surface is a pre-requisite for
its turnover. Within several minutes, dynamic tubular-like extensions carrying
Panx1 pinched off. This pattern of Panx1 internalization was quite distinct from
the rapid internalization of the double membrane structure of Cx43 that bud from
preexisting gap junction plaques, and enter one of the two neighboring cells
[101]. The tubular morphology of Panx1 extensions is quite intriguing and hints to
the possibility of its internalization via pathways independent of clathrin, caveolin
and dynamin GTPase. Glycosyl-phosphatidyl-inositol anchored proteins enriched
early endosomal compartments (GEECs) is one such example that results from
fusion of uncoated tubulovesicular clathrin-independent carriers (CLICs) directly
stemming from the plasma membrane [196]. Another feature of

the

CLICs/GEECs endocytic pathway is its independence from dynamin [197] and
dependence on actin polymerization machinery that is regulated by the Rho
family GTPase, Cdc42 [198]. As one of the documented binding partners of
Panx1 [153], it is possible that actin might regulate the endocytic process of
Panx1. One of the proposed models for actin-dependent endocytosis is the
elongation of plasma membrane invaginates into a tubular structure through
active polymerization, followed by scission via myosin motor proteins [199, 200].
Such association of actin and myosin II has been reported for endocytosis of
Cx43 double membrane structures (e.g. connexosomes) [201], and needs to be

167

further investigated in the case of Panx1. Another candidate that has been linked
to actin remodeling is endosomal-associated GTPase, ADP, ribosylation factor 6
(Arf6) [202, 203]. The Arf6-mediated pathway is not only independent of dynamin
and clathrin [204] but is also implicated in the endocytosis and recycling of K+
channels [205].

Interestingly, the Arf6 dependent pathway also includes the

formation of tube-like structures that are eventually used for recycling the cargo
back to the plasma membrane [206]. Although the Arf6 pathway needs further
investigation, it is tempting to speculate that the observed collapse of Panx1-GFP
tubules back onto the plasma membrane might take advantage of this
mechanism.
Once internalized, degradation of Cx43 is linked to both lysosomal [106] and
proteasomal pathways [171], while consistent with the previous report, our
current study suggests a role of lysosomes in Panx1 degradation [47]. In our
studies, while BFA blocked the cell surface trafficking of Panx1, consistent with
increased Gly1 levels, it did not interrupt Panx1 turnover from the cell surface, as
revealed by the loss of the Gly2 species. Surprisingly, chloroquine induced a
robust increase in the Panx1 Gly1 species, which correlated with Panx1
localizing to the perinuclear region. It is possible that long term blockage of
lysosomal function initiated a negative-feedback mechanism causing Panx1 to
bypass normal targeting to the cell surface trafficking and direct trafficking to
lysosomes. Collectively, the sustained expression of the Gly2 species in the
presence of chloroquine, together with a subtle rescue of the BFA-induced loss
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of the Gly2 species, supports that Panx1 typically cycles through the plasma
membrane en route to lysosomes for final degradation.
In summary, since Panx1 forms large pore channels implicated in: neuronal
necrosis [78], epileptic seizure-like activity [66] and initiation of the death complex
with the P2X7 receptor [72], our study was designed to characterize mechanisms
related to Panx1 turnover and degradation as potential regulatory mechanisms of
overall Panx1 function. Our study is the first to show that the turnover of Panx1 is
slow and is mediated via unique tubular-like extensions.
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CHAPTER 5: DISCUSSION and CONCLUSIONS
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5.1 DISCUSSIONS and CONCLUSIONS
Objective 1: To characterize the subcellular distribution of Panx1 and Panx3, to
identify the secretory pathway involved in Panx1 and Panx3 cell surface
trafficking, to analyze the mobility dynamics of GFP-tagged Panx1 and Panx3 at
the cell surface and to assess the role of the cytoskeleton in Panx1 trafficking
and cell surface dynamics.
Our study was the first to reveal that ectopically expressed Panx1 and Panx3
trafficked to the cell surface via the ER-Golgi in a Sar1-mediated COPIIdependent manner [153]. Once at the plasma membrane both pannexin
members predominantly localized in a relatively uniform manner, as well as in
dynamic cell surface protrusions [153]. Distinct from Cx43 [96], Panx1 and Panx3
were highly mobile at all plasma membrane domains [153]. In addition, Panx1
and Panx3 revealed no interdependency on microtubules for their cell surface
delivery or mobility [153], as reported for Cx43 [88]. Interestingly, intact
microfilaments facilitated the free movement of Panx1 carrying vesicles and
provided overall stability at the cell surface [153]. This study also identified actin
as a novel direct binding partner of Panx1 at the carboxyl terminal tail [153].
Objective 2: To identify the role of the carboxyl terminal tail in Panx1 trafficking
and homomeric interactions.
To investigate the role of the carboxyl terminal tail (C-tail) of Panx1 in trafficking
and homomeric interactions, we truncated the polypeptide at residue 307
(Panx1T307) and ectopically expressed the mutant in BICR-M1Rk and HEK-293T,
cells devoid of Panx1. Truncation of the Panx1 C-tail dysregulated its cell surface
delivery resulting in the mutant being retained predominantly in the ER.
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Furthermore, enzyme-based de-glycosylation experiments revealed that the
Panx1T307 mutant was glycosylated, albeit, to only the high mannose species.
Interestingly, co-expression of Panx1 could not rescue the delivery of the
Panx1T307 mutant to the cell surface and these species had limited co-interaction.
Thus, these results suggest that the Panx1 C-tail plays a role in oligomerization.
While our study fully supports the previously reported lysosomal-mediated
degradation of full length Panx1 [47], our data also supports proteasomal-based
degradation of mutant Panx1.
Objective 3: To explore the pathways for Panx1 internalization and degradation.
Using the pharmacological inhibitors of protein synthesis (cycloheximide) and
protein trafficking (BFA), we discovered that Panx1 had a much longer predicted
half-life compared to Cx43 [25]. To uncover the mechanism(s) responsible for
Panx1 internalization, this study focused on determining the putative involvement
of clathrin-, caveolin- and dynamin- mediated pathways. Although co-distribution
of Panx1 with clathrin and adapter protein (AP2) was observed at the cell
surface, no interaction was detected. This suggested that clathrin-mediated
internalization may not play a role in Panx1 internalization. Similarly, Panx1 also
co-distributed with caveolin (Cav)-1 and Cav-2 at the cell surface as well as
within intracellular compartments. However, co-immunoprecipitation assays
together with methyl-β cyclodextrin-induced disruption of membrane rafts
supported the position that Panx1 internalization was independent of caveolins.
Inhibition of dynamin (DynII) GTPase (characterized in budding off membranebound vesicles) by a dominant-negative GTP hydrolyzing mutant, K44A DynII
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and the pharmacological inhibitor, dynasore, further revealed that Panx1 turnover
was independent of dynamin. Interestingly, rapid time lapse imaging revealed a
novel internalization pattern of Panx1 along dynamic tubular extensions.
Although Panx1 degradation through the lysosomal pathway was previously
reported [47], we found that the high mannose species of Panx1 is accumulated
in the presence of the chloroquine-mediated inhibition of lysosomes. This finding
was also correlated with increased perinuclear Panx1 distribution and sustained
cell surface localization of Panx1.

While Cx43 gets degraded through both

lysosomal and proteasomal pathways [105], our study strongly supports the
premise of Panx1 degradation through lysosomes.

5.2 CONTRIBUTIONS of the RESEARCH
Prior to this study, the dynamics, regulatory binding partners, pathways and
compartments involved during the life-cycle of pannexins were essential
unknown. The overall goal of this study was to investigate if pannexins share
similar properties to Cx43 gap junctions based on their trafficking, mobility,
turnover and degradation characteristics. These studies were the first in the field
to combine GFP tagging and rapid time-lapse imaging to closely monitor and
address the dynamic properties of pannexins in live mammalian cells. In these
studies we showed that except for sharing a common secretory pathway, Panx1
and Panx3 are quite distinct from Cx43. Basically, Panx1 and/or Panx3 exhibited
a: a) relatively uniform cell surface distribution, b) extensive and rapid mobility at
the cell surface, c) prolonged turnover kinetics, and d) unique internalization
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properties within dynamic tubular extensions that were independent of pathways
mediated by clathrin, AP-2, Cav-1, Cav-2 and DynII.

5.2.1 Compared to Cx43, Panx1 and Panx3 exhibit
distinct subcellular distribution properties, cell surface
dynamics and cytoskeletal dependency
While an uniform cell surface distribution of Panx1 and Panx3 is the
predominant phenotype observed when these pannexins are expressed in
reference cell models, additional studies have highlighted other subcellular
distribution profiles that include diffused localization throughout the cell body and
punctate cell surface localization [36, 59, 125, 153]. Endogenously expressed
Panx1 revealed three distinct profiles: a) the relatively uniform cell surface
pattern at the cell surface of melanoma cells (B16-BL6) [153], and Madin-Darby
canine kidney cells [47], b) a cell surface punctate pattern as observed in: human
facial epidermis [25] and Hensen, Claudius and Boettcher cells of the rat cochlea
[36], and c) diffused cell body localization as seen in an mouse osteoblast cell
line (MC3T3-E1) [125], spiral limbus and spiral prominence in the rat cochlear
lateral wall [36], and murine spleen [25]. Whereas endogenous expression of
Panx3 was found to be within intracellular compartments in rat cochlear bone
[36], mixed patterns of localization were found both at the

cell surface and

cytoplasmic localization in murine chondrocytes and chondrogenic cell lines
(ATDC5) [37]. The differential distribution profiles of Panx1 and Panx3 suggest
that they may have distinct cellular roles. While the uniform cell surface
distribution of Panx1 supports the function of cellular communication with the
extracellular environment -through formation of non-junctional membrane
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channels [25, 55], the intracellular localization of pannexins suggests that they
serve alternate roles. In the study conducted by Vanden Abeele et. al., [54],
intracellular localized Panx1 was proposed to regulate ER-based calcium
homeostasis. However, later we showed that Panx1 dysregulated keratinocyte
differentiation while Panx3 maintained the epidermal integrity of murine skin [67].
In addition, our current study revealed a unique enrichment of Panx1 and Panx3
in dynamic cell surface protrusions, at areas that are devoid of contacting cells
[153]. While similar distribution of Panx3 in cellular extensions supported its role
in ATP release and chondrogenic differentiation [37], this phenomenon was not
typically observed for Cx43, unless non-functional Cx43 mutant was ectopically
expressed [96].

Collectively, these results support our hypothesis that the

pannexin family of proteins exhibits a more diverse subcellular localization than
connexins, broadening their potential cellular roles.
The cell surface clustering of Cx43 and the relatively uniform distribution of
Panx1 and Panx3 [153] also supports that these families of proteins acquire
different states of assembly. In fact, the rapid lateral movement of Panx1 and
Panx3 in all plasma membrane microdomains [153], suggests that pannexins are
likely not packaged into dense crystalline-like structures, as reported for Cx43
[39]. Pannexin channel packing and cell-cell interactions may be inhibited by
steric hindrance provided by the bulky carbohydrate moieties at the extracellular
domain, prohibiting the close proximity of the two adjacent cells.

Electron

micrographs of Panx1 at the cell surface depicting 20-50 nm of intercellular
spacing, as opposed to 2-4 nm for Cx43 [47], further supports this notion. The
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greater mobile fraction of Panx1 and Panx3 in comparison to Cx43 [153], could
also suggest less interactions with scaffolding proteins and

cytoskeletal

elements.
In our study, nocodazole-induced disruption of microtubules did not significantly
alter the cell surface distribution of Panx1 and Panx3 [153]. However, this finding
was quite distinct from Cx43, where the regeneration of gap junction plaques and
cell surface mobility was minimal upon nocodazole exposure [88, 89], suggesting
that the delivery of Cx43 was much more dependent on microtubules, as
compared to Panx1 and Panx3. On the other hand, disruption of microfilaments
revealed concomitant intracellular accumulation of Panx1 and Panx3 leaving only
a subpopulation at the cell surface. In contrast, Cx43 gap junctions remain
relatively more independent to the assembly states of microfilaments [141],
thereby suggesting that the connexin and pannexin family of proteins have
distinct dependency on cytoskeletal elements for their cell surface transport,
mobility and stability.

5.2.2 The carboxyl terminal tail of Panx1 facilitates its
trafficking and homomeric interaction
Several studies have identified the effect of single amino acid substitutions within
specific motifs of Panx1 [25, 47, 63, 151, 152], however, deletion of an entire
Panx1 domain has never been investigated. We were particularly keen on
identifying the role of the C-tail, as this cytoplasmic exposed domain was
considered a prime candidate for interaction with other regulatory proteins. In
fact, our work identified that Panx1 C-tail serves as a substrate for direct binding
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with actin that may provide multifaceted functions in Panx 1 transport, cell
surface mobility and stability [153].
Using a truncated mutant of Panx1 lacking the last 119 amino acids from the Ctail, our study suggested that the C-tail was important in trafficking, homomeric
interactions and targeted degradation through lysosomes. First, we identified that
in the absence of the C-tail, Panx1 mutant failed to traffic to the cell surface.
Second, the Panx1 C-tail truncated mutant was retained primarily within the ER
where it was found as a core (Gly0) or high-mannose (Gly 1) species. Third, the
Panx1 C-tail mutant failed to substantially interact with the full length Panx1,
suggesting a role of the C-tail in homomeric oligomerization. Finally, the ERretained truncated mutant was directed to proteasomes for degradation, thus
supporting the involvement of the endoplasmic reticulum associated degradation
(ERAD) pathway. Since ERAD is associated with premature degradation of
misfolded proteins [159, 165], we speculate that the C-terminus may also play an
important role in the proper folding of Panx1.

5.2.3 Distinct from Cx43, Panx1 exhibits a longer halflife and internalizes via unique tubular-like extensions
In these studies, we showed that the internalization of the cell surface pool of
Panx1 exceeds the 1.5-3 hrs of Cx43 turnover [25] with an estimated half-life in
excess of 10 hours. While removal of Cx43 from the cell surface involved
internalization of the entire or fragments of gap junctions as connexosomes [13]
into one of the two contacting cells [101], the removal of Panx1 form the cell
surface appeared to follow tubular extensions. Mechanistically, rapid Cx43
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internalization was aided by several molecular players such as: dynamin,
clathrin, AP-2, actin and myosin [102, 104, 201]. However, the internalization of
Panx1 as noted in our study was independent of clathrin, AP-2, dynamin and
caveolin-driven pathways. Given the direct association of the Panx1 C-tail with
microfilaments, it is possible that the internalization of Panx1 might be actinmediated. Our studies also supported the lysosomal degradation of internalized
Panx1. Since Panx1 channel function is linked to neuronal necrosis, epileptic
seizures-like activity and activation of death complex of P2X7 receptor [66, 72,
78], our study provides a means of regulating the channel function by processes
of internalization and degradation.

5.3 LIMITATIONS and FUTURE DIRECTIONS
5.3.1 Limitations
In order to identify the dynamic properties of pannexins in live cells, we tagged
Panx1 and Panx3 with GFP. Although, Panx1-GFP revealed trafficking and
localization pattern similar to its wild-type (WT) counterpart, the GFP tagging of
Panx3 caused a severe trafficking defect [25] with only a trace amount available
at the cell surface. This posed a limitation in collecting quantifiable data for
Panx3 mobility at distinct microdomains of plasma membrane. To overcome this
setback, we co-transfected the untagged Panx3, as it facilitated the adequate
delivery of Panx3-GFP to the cell surface for assessment of the mobile fraction.
The comparable percentage (40-50%) of mobile fractions of Panx3-GFP (coexpressed with Panx3) and Panx1-GFP (co-expressed with Panx1) further
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suggested that co-expression with the WT counterpart does not hinder the
mobility of pannexin family members at the plasma membrane.
In addition, while tagging of Panx1 C-tail truncated mutant with RFP identified its
role in trafficking, we were unable to parallel our findings using the untagged
counterpart due to the lack of a quality antibody. It was expected that our
previously generated antibodies against Panx1 extracellular domain [59], would
serve as a tool to detect the C-tail truncated mutant of Panx1; however, our
antibody detection was deemed to be inadequate. Therefore, to control for any
possible adverse effects of the RFP tag, we also tagged the full length Panx1
with RFP to be used in comparative studies. Since RFP tagging of full length
Panx1 exhibited similar distribution characteristics as the untagged counterpart, it
was employed as a control to study the biological properties of the Panx1 C-tail.

5.3.2 Future Directions
Based on our studies, it is clear that pannexins are a distinct family of proteins,
as compared to connexins. Part of this distinction may arise from differential
regulation, based on protein-protein interactions. While Panx1 was identified to
directly interact with actin, it remains to be investigated which motif within the
Panx1 C-tail binds to actin. Consistent with other reports [207, 208], one possible
approach for identifying the actin binding site within Panx1 is by using serial
truncations of the C-tail. In addition, it would be interesting to determine if Panx3
also interacts with actin, as its cell surface localization is also perturbed in
response to disrupted microfilaments [153]. Although our studies identified a role
of microfilaments and microtubules in the plasma membrane distribution of
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Panx3, it has yet to be examined if these cytoskeletal elements play a role in the
cell surface mobility of Panx3.
It has been postulated that the overall cellular function of pannexins can be
regulated, in part, by appropriate trafficking and turnover to/from the plasma
membrane. While deletion of almost the entire Panx1 C-tail provided evidence for
its role in the cell surface trafficking, future research should focus on determine if
there are any targeting motifs within the C-tail that regulate Panx1 trafficking. In
addition, investigating the role of the C-tail should also be extended to Panx3.
Our studies also suggest that Panx1 is a long-lived protein; however, it remains
to be determined if Panx3 also exhibits a prolonged half-life. While Panx1
internalization was associated with unique tubular-like extensions budding away
from plasma membrane, the underlying mechanism remains unclear. Since the
endocytosis of Panx1 was found to be independent of clathrin, AP-2, dynamin
and caveolin-driven pathways, we speculate that the Panx1 binding protein, actin
might play a role in its internalization. One of the proposed models of actinmediated internalization is the elongation of plasma membrane invaginates into a
tubular structure through active polymerization, followed by scission via myosin
motor proteins [199, 200]. Since such association of actin and myosin II has also
been reported for endocytosis of Cx43 as connexosomes [201], future studies
should pursue this hypothesis to investigate how Panx1 is internalized via tubular
extensions.
In summary, our studies support the hypothesis that in comparison to Cx43,
Panx1 and Panx3 exhibit distinct subcellular distributions, cell surface mobilities,
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and cytoskeletal dependencies, while Panx1 possesses unique turnover
dynamics, and mechanistic pathways leading to its internalization and
degradation.
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